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Abstract 
Huntington Disease (HD) is an inherited neurodegenerative disease caused by a CAG 
repeat expansion in the gene encoding the huntingtin protein. The resultant mutant 
huntingtin triggers numerous and severe neuronal abnormalities. Although motor deficits 
manifest during midlife, subtle cognitive aberrations can be detected prior to the onset of 
an overt behavioural phenotype. However, knowledge surrounding the cognitive deficits 
in the early stages of HD is scarce. Here, we studied hippocampal synaptic properties, 
including activity-dependent plasticity and nanoscale architecture in a mouse model of 
HD prior to the onset of motor symptoms. We focused on the hippocampus due to its 
involvement in cognitive function and the debilitating cognitive symptoms described by 
HD patients. Multi-electrode array recordings of synaptic activities revealed impairments 
in plasticity, while super-resolution microscopy elucidated clear alterations in synaptic 
nanoarchitecture of the hippocampus. Our data demonstrate detrimental effects of mHtt 
expression on hippocampal structure and function in presymptomatic HD.  
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1-0 Introduction 
 
1-1 Overview of Huntington disease   
Huntington Disease (HD) is an autosomal dominant neurodegenerative disorder 
with midlife onset characterized by an array of motor, cognitive, and psychiatric 
symptoms. It affects approximately 1 in 10,000 people globally (Fisher and Hayden, 
2014), with death usually occurring 12-15 years after motor symptom onset. HD is caused 
by a cytosine, adenine, and guanine (CAG) repeat expansion on chromosome 4, which  
translates into an aberrantly long polyglutamine tract at the N-terminus of the huntingtin 
protein (htt);(MacDonald et al., 1993; Ravikumar et al., 2004). The age of HD onset is 
inversely correlated with the length of the CAG repeat expansion. In patients who have 
36-39 repeats, penetrance is variable, with full penetrance arising at 40 or more repeats 
(Ross et al., 2014). Moreover, age of onset as well as rate of progression of HD are likely 
to be influenced by environmental and genetic factors (Wexler et al., 2004). According to 
current criteria, onset is characterized as the point when a person develops explicit 
presence of otherwise unexplained extrapyramidal movement symptoms such as 
hyperkinetic “dancelike” movements known as chorea (Hogarth et al., 2005).  
Htt is a cytoplasmic protein that is highly expressed in human tissue, particularly 
in the brain in areas such as the striatum and cerebral cortex. Unlike many other proteins 
of similar size (348 kDa), Htt is completely soluble and ubiquitously expressed both 
within and outside the central nervous system (CNS);(Cattaneo et al., 2005). Htt is 
imperative for embryonic development and plays a role in physiological intracellular 
processes such as gene transcription, protein and organelle trafficking, and mitochondrial 
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function (DiFiglia et al., 1995; Nasir et al., 1995; Cattaneo et al., 2005; Sepers and 
Raymond, 2014). Previous research indicates that mutant huntingtin (mHtt) protein’s 
toxicity is directly related to the CAG repeat length described above (Andrew et al., 1993; 
Snell et al., 1993). More recently it has been suggested that loss of normal or wild-type 
(WT) huntingtin function may also contribute to the pathogenesis of HD. It is known that 
increased WT huntingtin expression improves CNS cell survival and helps to mitigate the 
effect of mutant protein (Rigamonti et al., 2000; Zuccato et al., 2001, 2003). Furthermore, 
total knock-out of WT huntingtin is lethal to mice in utero, and deletion of the WT allele 
in animal models of HD causes exacerbated neuropathology (Bates, 2003; Gauthier et al., 
2004; Van Raamsdonk et al., 2005a).  
1-2 Motor symptoms associated with Huntington Disease  
 The motor component of HD can broadly be divided into two categories. The first 
category encompasses involuntary movements, specifically chorea (Ross et al., 2014). 
HD is often referred to as Huntington chorea and chorea was first described by George 
Huntington in 1872 as “the name given to the disease on account of the dancing 
propensities of those who are affected by it” (Huntington, 1872). It can also be classified 
as the occurrence of rapid, irregular, and arrhythmic uncontrolled movement (Smith et al., 
2000). Chorea is most prominent in adult-onset HD and gives the disease its stereotypical 
clinical manifestation of uncontrolled and sporadic movement. The second category 
involves impairment of voluntary movements and includes bradykinesia and rigidity. This 
aspect of the disease tends to appear in the late stages of HD and progresses more steadily 
than chorea (Rosenblatt et al., 2006). The motor dysfunction associated with HD stems 
 
 
3 
from significant and progressive atrophy of the basal ganglia, particularly the caudate 
nucleus and putamen, where the rate of atrophy is greater for patients with earlier onset of 
symptoms (Aylward et al., 1997). This atrophy involves loss of neurons in conjunction 
with astrogliosis (Vonsattel et al., 1985). Moreover, the involuntary movement 
component associated with HD is most often attributed to interruption of motor and 
cognitive basal ganglia loops. The loss of enkephalin-containing medium spiny neurons 
(MSNs) in the striatum that are part of the indirect pathway has been measured as 
decreased striatal dopamine D2 receptor binding with Positron Emission Tomography 
(PET);(Alexander et al., 1986; Reiner et al., 1988; Albin et al., 1989). Moreover, the 
preferential degeneration of MSNs in the indirect pathway from the caudate nucleus to 
the globus pallidus external reduces inhibitory control of the indirect pathway, resulting 
in choreic movements (Crook and Housman, 2012). 
1-3 Psychiatric and cognitive symptoms associated with Huntington Disease  
Although motor aberrations associated with HD do not usually manifest until the 
fourth or fifth decade of a patient’s life, a wide array of research has shown that subtle 
abnormalities in psychiatric and cognitive functioning are present much earlier. This 
period of pre-motor symptomology is known as the prodrome (i.e. presymptomatic). The 
investigation into early psychiatric and cognitive symptoms of HD could help mitigate the 
detrimental effects on day-to-day functioning and quality of life. Psychiatric 
manifestations in HD include depression, apathy, irritability, obsessions, and occasionally 
psychosis (Paulsen et al., 2001; Julien et al., 2007; van Duijn et al., 2007). As previously 
stated, there is a direct association between the number of CAG repeats and age of onset 
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of motor symptoms in HD; however, there has been a reported unexplained temporal 
variability in the presentation and severity of psychiatric symptoms (Epping et al., 2016). 
To investigate this unexplained temporal variability, TRACK-HD was developed. 
TRACK-HD is a multinational longitudinal observational study in presymptomatic 
participants carrying the HD mutation designed similarly to a clinical trial. It employs 
rapid study design and data acquisition, stringent quality control, and blinded data 
analysis (Tabrizi et al., 2009). The primary aim of TRACK-HD is to provide advances in 
methodologies for disease-modifying clinical trials. TRACK-HD utilizes the known 
genetic cause of HD to optimize detection of psychiatric and cognitive changes in carriers 
of the HD gene who have yet to exhibit motor symptoms (Tabrizi et al., 2011). 
Interestingly, data from TRACK-HD indicated a significant increase in apathy over a 36-
month period in pre-clinical HD mutation carriers. This is indicative of a more clear 
linear progression of psychiatric symptomology than previously understood (Tabrizi et 
al., 2013). 
Cognitive impairments and how they relate to the pathophysiology and 
progression of HD are a little more widely studied than their psychiatric counterpart, 
however are still quite ambiguous. It is well known that cognitive impairments 
materialize years before the clinical diagnosis of HD, in the prodromal period. These 
impairments include poor performance on evaluations of attention, working memory, 
episodic memory, processing speed, psychomotor functions, emotional processing, and 
executive function (Paulsen et al., 2001; Johnson et al., 2007; Stout et al., 2007, 2011). 
There is no standard battery of testing for the cognitive assessment of HD, although many 
clinicians rely on the Unified Huntington Disease Rating Scale (UHDRS). This scale 
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includes the symbol digit modality test, the Stroop color word test, and a verbal fluency 
test (Huntington Study Group, 1996). Research suggests that cognitive impairment is one 
of the most debilitating aspects of the disease and is most highly associated with 
functional decline (Nehl et al., 2004; Paulsen, 2011). The cognitive symptoms associated 
with HD often develop approximately 15 years prior to the motor diagnosis and are 
tightly related to brain volume loss on Magnetic Resonance Imaging (MRI);(Aylward et 
al., 2011).  
Many researchers attribute impairments in cognitive function in HD to 
dysfunction of the striatum and fronto-striatal circuits (Vonsattel et al., 1985; Snowden et 
al., 2002). One of the most common and persistent cognitive deficits observed in HD 
patients during pre-clinical stages is difficulty in tasks requiring a shift in strategy 
(Marder et al., 2000). Interestingly, this abnormal response is thought to stem from the 
inability to inhibit a previously learned response and is likely mediated by the interaction 
between striatal neurons and neighboring aspiny cholinergic interneurons (Swerdlow et 
al., 1995; Mink, 1996). Impairment in cortico-striatal function also holds true in neuro-
imaging studies. A study employing functional MRI (fMRI) described decreased activity 
in both the frontal cortex and putamen of presymptomatic HD patients undergoing a serial 
reaction time test (Kim et al., 2004). At more advanced stages, dementia increasingly 
develops, resulting in alterations in a multitude of cognitive functions including slow 
information processing, depression, apathy, and changes in personality (Paulsen et al., 
1995).  
Along with the plethora of research surrounding the cortico-striatal system, it is 
also becoming increasingly evident that HD is a brain wide phenomenon, with emphasis 
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being placed on extrastriatal regions. HD patients in the prodromal period display 
significantly delayed response latencies on a pattern-recognition task in comparison to 
non-carriers (Lawrence et al., 1998). Furthermore, presymptomatic HD mutation carriers 
display aberrations in associative learning and spatial working memory on a foraging-for-
reward task involving searching for tokens through a number of colored boxes (Lawrence 
et al., 2000; Berrios et al., 2002). These studies suggest an involvement of the 
hippocampus, a brain area imperative for cognitive function, specifically in learning and 
memory. As a result of the brain-wide nature of HD, researchers and clinicians alike are 
continuing to develop techniques such as powerful microscopy paradigms and cognitive 
clinical testing to further investigate outcomes related to HD that may offer insight into 
the cellular pathophysiology and subsequent progression of the disease. It is of utmost 
importance to identify the earliest detectable cellular abnormalities associated with HD, in 
order to initiate pre-clinical investigation into targeted treatments for the disease.  
1-4 The hippocampus  
 The hippocampal formation, one of the most widely studied neuronal systems in 
the brain, is a seahorse shaped structure located deep in the medial temporal lobe (Bird 
and Burgess, 2008). There are three well-studied anatomical subdivisions of the 
hippocampus: CA1, CA3, and dentate gyrus (DG). The principle neurons in the CA 
regions are known as pyramidal neurons and they comprise about 90% of all neurons in 
these regions. Recently, it has been established that there is a high amount of 
heterogeneity among cell populations in the hippocampus, where a high degree of 
transcriptional variability across the long axis of hippocampus has been described 
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(Cembrowski et al., 2016). Specifically, excitatory pyramidal cells in CA1 and CA3, as 
well as granule cells, previously considered to be homogenous populations, show a 
striking degree of molecular diversity along the long axis (dorsal-ventral) obtained by 
examination of gene expression patterns (Thompson et al., 2008; Cembrowski et al., 
2016). Notably, this dorsal-ventral heterogeneity can exhibit even further organizational 
boundaries. For example, CA3 pyramidal cells have been shown to form discrete 
subpopulations, with over 300 genes identified with robust regionalized expression 
patterns, while CA1 pyramidal cells and DG granule cells do not show the same 
subpopulation conformity (Thompson et al., 2008; Cembrowski et al., 2016).   
The hippocampus is imperative for acquisition, temporary storage, and retrieval of 
explicit memory for facts and events (i.e. declarative memory);(Zola-Morgan and Squire, 
1990). Patients with selective damage to the hippocampus exhibit impairments in 
acquiring new, consciously accessible memories while short-term memory, priming, and 
procedural learning that were acquired before the damage are often preserved (Zola-
Morgan et al., 1986; Milner et al., 1998). It is becoming clear that the hippocampus plays 
a much more complex role in cognitive processes than its function in declarative memory; 
and has been highly implicated in spatial cognition. It was shown that rats placed in an 
open field to measure spatial memory exhibited high firing rates of particular cells, 
known as “place cells” in the hippocampus when in a particular place and orientation. 
Conversely, when the animal is in other locations in the open area, the same cells show no 
firing (O’Keefe and Dostrovsky, 1971). The hippocampus has also been implicated in 
temporal processing. For example, researchers have investigated hippocampal responses 
during trace-associative eyeblink conditioning. They wanted to assess hippocampal 
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neuronal firing patterns during the time period between an auditory cue and a delivered 
air puff to the eye. It was found that hippocampal pyramidal neurons fire repeatedly over 
the period of time between the conditioned stimulus (auditory cue) and unconditioned 
stimulus (puff to the eye), appearing to serve as a “time-keeping” or anticipatory role 
(McEchron and Disterhoft, 1997; McEchron et al., 2003). Moreover, the hippocampus 
has been implicated in the ability of rats to remember the sequences of odor presentation. 
It was found that hippocampal lesions produced an impairment in the ability of rats to 
remember the presentation of odors over an extended period of time, despite an intact 
ability to remember odors they recently encountered (Agster et al., 2002; Fortin et al., 
2002). The hippocampus has also been implicated in formation of in-depth 
representations of complex environmental cues. A non-matching-to-sample test involving 
olfactory cues in small cups in numerous locations within an open field was conducted 
with rats. In this task, the animal had to learn that if the odor in any cup did not match the 
odor presented immediately previous to it, they would receive a reward. During this task, 
researchers observed hippocampal cells firing specifically to place, odor, as well as cells 
that fired selectively on an odor match or non-match (Wood et al., 1999). Again, this 
study helps to highlight the complex and multifaceted nature of the hippocampus. 
 Taking all these pieces of evidence into consideration, it is apparent that the 
hippocampus plays vital and complex roles in an array of cognitive processes. 
Unfortunately, hippocampal involvement in the highly burdensome cognitive deficits 
observed during the progression of HD has hardly been studied and requires much more 
in-depth and precise research. The hippocampus is of specific importance because the 
majority of hippocampal deficits in HD have been characterized only in late-stage 
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(symptomatic) models, therefore it is plausible that these deficits are manifesting much 
earlier on in disease progression when early cognitive deficits are seen. Utilizing novel 
and more sensitive measures to investigate the properties of hippocampus can help 
researchers determine whether the presymptomatic HD accompanies deficits in synaptic 
structure and/or plasticity in the hippocampus that are contributing to the pathophysiology 
of the disease.  
1-5 Early cognitive dysfunction in animal models of Huntington Disease 
The modelling and subsequent investigation of disease in animals is a hallmark of 
the scientific field. With rapid gestation and lifecycle periods, in combination with many 
similar anatomical and physiological features to humans, modelling and investigating 
human disease in a variety of animal species has led to many impactful scientific 
discoveries. In the case of HD, several different mouse models have been developed 
based on the known single gene mutation, which may recapitulate many critical 
neuroanatomical and physiological CNS features of HD patients (Dalley et al., 2004),. 
Many of these models exhibit significant similarities to the human disease, but are also 
significantly different (Brooks and Dunnett, 2013);(Table. 1). For the purposes of this 
thesis, we utilized a clinically relevant mouse model of HD, Q175FDN. This model of 
HD, specifically the heterozygous knock-in (KI) used for all experiments in this thesis, 
shows slowly progressing disease phenotype, expresses human mhtt, and closely 
resembles the genetic mutation that causes HD, and for this reason is a valuable model for 
pre-clinical investigation (Southwell et al., 2016). The Q175FDN model has an excised 
floxed neomycin (neo) cassette that is known to interfere with mhtt gene expression, 
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specifically causing partial loss of gene function, making the redesigned Q175FDN model 
a more relevant mouse line than its predecessors (Southwell et al., 2016). It is important 
to note that heterozygous Q175FDN mice do not exhibit any detectable behavioural 
deficits until 6 months of age (Southwell et al., 2016), and all of the experiments for this 
thesis were carried out at 3 months of age.  
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Table 1. Mouse models of Huntington Disease.  
Table adapted from (Menalled and Chesselet, 2002; Gray et al., 2008; Menalled et al., 
2012; Pouladi et al., 2013; Southwell et al., 2016). 
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Model 
 
Transgene 
Product 
Promotor CAG 
Repeat 
Length 
Earliest 
abnormal 
behaviour 
Age at death 
Truncated 
N-terminal 
fragment 
models 
Express shortened fragments of mhtt and typically exhibit a rapid onset of 
symptoms. 
R6/1 67 amino 
acids of N-
terminal 
fragment 
(human htt) 
1 kb human 
htt promoter  
116 15-21 weeks 
(wheel clasping)  
32-40 weeks 
R6/2 67 amino 
acids of N-
terminal 
fragment 
(human htt) 
1 kb human 
htt promoter 
144 5-6 weeks (motor 
deficits)  
10-13 weeks 
HD94 67 amino 
acids of N-
terminal 
fragment 
(chimeric 
human 
htt:mouse htt 
exon 1) 
CamkIIa 94 4 weeks (wheel 
clasping) 
Normal 
lifespan 
Full-length 
models 
(knock in) 
Transgenic models involve human mhtt being inserted into the mouse genome. The 
mouse will express this mutant gene in addition to two normal copies of 
endogenous mouse htt. 
HdhQ92 Full-length 
chimeric 
human htt 
exon 1:mouse 
htt 
 
Endogenous 
mouse htt 
promoter 
92 Not observed (up 
to 17 months) 
Normal 
lifespan 
HdhQ111 Full-length 
chimeric 
human htt 
exon 1: 
mouse htt 
Endogenous 
mouse htt 
promoter 
111 24 months (gait 
deficits)  
Normal 
lifespan 
Hdh94 Full-length 
chimeric 
human htt 
Endogenous 
mouse htt 
promoter 
94 2 months (mild 
hyperkinesia)  
Normal 
lifespan  
 
 
13 
exon1: mouse 
htt 
zQ175 Full-length 
chimeric 
human htt 
exon1: mouse 
htt 
Endogenous 
mouse htt 
promoter 
188 4 weeks 
(homozygous- 
grip strength) 
 
4.5 months 
(heterozygous- 
reduced rearing in 
open field)  
Significantly 
reduced 
lifespan 
reported 
(sudden death 
from seizures 
in 
homozygous)  
*Q175FDN Full-length 
chimeric 
human htt 
exon1: mouse 
htt – excised 
neo cassette 
from Q175F 
mice 
generating a 
new line 
Endogenous 
mouse htt 
promoter 
>200 3 months 
(homozygous-
object 
recognition/object 
location deficits)  
 
6 months (object 
recognition 
deficits)  
Homozygous- 
death 
observed at 9 
months  
 
 
Heterozygous 
death 
observed at 13 
months  
Full-length 
models 
(transgenic)  
Created using yeast artificial chromosome (YAC) or bacterial artificial 
chromosome (BAC) technology. Such models express human genomic mutant htt 
transgenes. Behavioural and neurodegenerative phenotypes tend to be more 
severe than KI models 
YAC128 Full-length 
human htt 
Human htt 
promoter and 
regulatory 
elements (24 
kb 
upstream, 117 
kb 
downstream) 
128 6 months (rotarod 
deficits)  
Not reported 
YAC72  Full-length 
human htt 
Human htt 
promoter and 
regulatory 
elements 
72 7 months 
(hyperkinesia)  
Not reported 
BACHD Full-length 
human htt 
Human htt 
promoter and 
regulatory 
elements (20 
kb upstream, 
50 kb 
downstream) 
97 2 months (subtle 
rotarod deficits)  
Not reported 
* Q175FDN heterozygous mice used for all reported experiments in this thesis  
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As previously mentioned, increased focus in both basic research and clinical settings is 
being placed upon identifying and characterizing cognitive abnormalities associated with 
HD. However, this area of HD is still remarkably understudied in relation to its reported 
burden on family members and caretakers, as well as the burden on the HD patient 
themselves. Cognitive decline in HD is highly associated with loss of functionality, and 
can be predictive of institutionalization (Paulsen, 2011). In mouse models of HD, the 
most widely reported behavioural deficit associated with cognition error is in reversal 
learning. Specifically, these mice show significant deficits in learning to efficiently locate 
a submerged platform after the location of the platform shifted during Morris water maze 
tasks (Murphy et al., 2000; Brooks et al., 2012). The neurological circuitry underlying 
this deficit is well known to be associated with the hippocampus as well as the anterior 
cingulate and orbitofrontal cortices. This may mediate a positive-feedback response in the 
fronto-striatal-thalamic loop (Clarke et al., 2008; Hampshire et al., 2012; Klanker et al., 
2013). Furthermore, visual discrimination learning and tactile-dependent learning, both of 
which are mediated by hippocampal function, are significantly altered in the R6/1 model 
HD mice (Mazarakis et al., 2005; Giralt et al., 2009). Landmark studies have 
demonstrated that transcription of the pro-survival factor brain-derived neurotrophic 
factor (BDNF) is increased by Htt and reduced by mHtt (Zuccato et al., 2001, 2003). 
BDNF has emerged as an important regulator of synaptic plasticity and is expressed in 
areas of the brain imperative to cognitive function such as the neocortex, hippocampus, 
cerebellum, and amygdala (Kawamoto et al., 1996; Kafitz et al., 1999). Reduced BDNF 
expression is observed in the striatum of presymptomatic YAC72 HD mice (Zuccato et 
al., 2001).  
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Cognitive testing designed to assess dysfunction in HD mice has revealed 
impaired hippocampal function. Specifically, spatial learning and navigation memories 
are abnormal in R6/1, R6/2, and HdhQ7/Q111 mouse models of HD. Hippocampal protein 
kinase A (PKA) activity contributes to R6/1 and R6/2 abnormalities. Increased PKA 
activity results in the hyper-phosphorylation of several membranous PKA substrates, 
occluding normal PKA-dependent processes, thus contributing to the deficits in learning 
and memory observed (Giralt et al., 2011). Furthermore, PKA pathway aberrations in 
HdhQ7/Q111 mice are associated with reduced hippocampal expression of cAMP response 
element binding (CREB) binding protein and diminished levels of histone H3 acetylation 
(Giralt et al., 2012). Neuronal CREB-mediated transcription regulates synaptic plasticity, 
mitochondrial function, and cell survival (Harjes and Wanker, 2003). In addition, in a 
study examining neurogenesis in the sub-ventricular zone and sub-granular zone of DG, 
hippocampal cell proliferation and neurogenesis were significantly reduced in R6/2 HD 
mice when compared to wild-type (WT) controls (Gil et al., 2005). Although the cellular 
and synaptic underpinnings of cognitive dysfunction are well documented in early-to-late 
symptomatic HD, with the majority of research being completed at this symptomatic 
stage, there is a substantial gap in the literature in relation to the earliest synaptic 
abnormalities that appear in the hippocampus of presymptomatic HD mutation carriers.  
1-6 Synaptic plasticity & transmission  
Synaptic plasticity, the activity-dependent modification of synapses, is an 
efficacious mechanism for shaping and adjusting the response properties of neurons 
(Abbott and Nelson, 2000). Long-term potentiation (LTP) and long-term depression 
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(LTD) of synaptic strength provide the framework for the majority of models of learning 
and memory. LTP was first described in 1973 when brief trains of high-frequency 
stimulation (HFS) were delivered to monosynaptic excitatory pathways in rabbit 
hippocampus and resulted in a sustained increased in the strength of synaptic transmission 
(Bliss and Lømo, 1973). LTP is expressed as a continual increase in the size of the 
evoked response, recorded from an individual neuron or populations of neurons (fig.1).  
It is widely accepted that many forms of LTP induction require the activation of 
postsynaptic N-Methyl-D-Aspartate receptors (NMDARs), a subtype of glutamate 
receptor. Although NMDAR-independent LTP is also a widely established phenomenon 
(Komatsu et al., 1991; Kanterewicz et al., 2000), here the focus will be on NMDAR-
dependent LTP. NMDAR activation requires depolarization of the postsynaptic cell, 
which is accomplished by repetitive and tetanic stimulation of synapses (Nicoll and 
Malenka, 1995).  During fast excitatory synaptic transmission, glutamate binds to a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptors (AMPAR) which are ion 
channels permeable to monovalent cations (Na+, K+) and provide the majority of inward 
current associated with post-synaptic responses. Furthermore, AMPARs that lack the 
specific subunit GluA2 are also permeable to the divalent cation Ca2+ (Man, 2011). The 
influx of positive current generated causes the postsynaptic cell to depolarize, allowing 
Mg2+ to dissociate from its position blocking the channel of NMDARs, granting Ca2+ to 
enter the cell. The subsequent rise in intracellular Ca2+ activates the downstream cellular 
pathways such as PKA and calpain that increase synaptic efficacy, resulting in LTP (Lu et 
al., 2001). 
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 LTP can be induced in many ways, most often by delivering tetanic stimulation to 
the neuronal pathway of interest (Bliss and Collingridge, 1993). The two most common 
forms of LTP induction by means of tetanic stimulation are theta-burst stimulation (TBS) 
and HFS. TBS most often consists of 10 bursts of 4-5 pulses at 100 Hz delivered at 200 
millisecond intervals (Abraham and Huggett, 1997). TBS is a physiologically-relevant 
stimulation paradigm and mimics two aspects of hippocampal physiology: spike 
discharges of pyramidal neurons and regulation of these cells during hippocampal theta 
rhythm (4-12 Hz);(Buzsáki, 2002; Larson and Munkácsy, 2015). HFS protocols are most 
typically executed at 100 Hz for 1 second (Bliss and Collingridge, 1993). Although 
widely used and extremely effective, HFS lacks the same physiological relevance as TBS 
(Albensi et al., 2007). LTP can also be induced chemically (cLTP) in a number of ways. 
The most common method involves bathing organotypic slices in glycine, a NMDAR co-
agonist, as well as artificial cerebrospinal fluid (aCSF) containing no magnesium. The 
lack of Mg2+ in this solution removes the Mg2+ from NMDAR receptors, allowing the 
influx of positive cations. (Otmakhov et al., 2004; Kopec et al., 2006). Although LTP is 
triggered within seconds for the protocols we describe above, it can last for hours in vitro 
and up to days in vivo (Malenka and Nicoll, 1999).  
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Figure 1. Schematic of basal transmission and LTP induction.  
Image on the left depicts synaptic transmission during basal conditions. RMP stands for 
“resting membrane potential”. In this image, we can see that the post-synaptic side is not 
depolarized therefore the Mg2+ block remains in the NMDAR and LTP cannot occur. 
Image on the right depicts synaptic transmission during LTP induction. Here, the post-
synaptic cell has depolarized sufficiently to cause the Mg2+ block to be removed from the 
NMDAR triggering an influx of Ca2+ and subsequent LTP. Adapted from (Malenka and 
Nicoll, 1999). 
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1-7 Dysfunction of the cortico-striatal synapse in prodromal Huntington Disease 
Electrophysiological studies in striatal slices derived from HD mouse models have 
revealed clear evidence for early neuronal dysfunction. For example, striatal neurons of 
presymptomatic R6/2 mice showed increased cell-membrane input resistance, lower 
stimulus intensity to evoke action potentials, and reduced paired-pulsed facilitation in 
comparison to WT controls (Klapstein et al., 2001). Furthermore, in presymptomatic 1-
month old YAC128 mice, pre-synaptic glutamate release and AMPAR-mediated synaptic 
currents were significantly increased, corresponding to an increased responsiveness of 
MSNs to cortical stimulation. Increased glutamate release could contribute to increased 
neuronal excitotoxicity and subsequent damage of the striatum (Joshi et al., 2009).  
Many studies have also observed early alterations in NMDAR activity in the 
striatum of HD mice. A significant alteration in NMDAR-mediated transmission in 
presymptomatic HD mice is seen as the persistent reduction of Mg2+ sensitivity. As 
previously mentioned, when the cell membrane is hyperpolarized or at rest, NMDAR 
channels are blocked by Mg2+. In a subset of striatal cells in an R6/2 model of HD 
however, NMDARs are activated at more hyperpolarized potentials, which could be 
detrimental to cell function (Starling et al., 2005). Moreover, there is a distinct link 
between the NMDAR subunit GluN2B, which is enriched in the striatum, and the effects 
of mHtt (Landwehrmeyer et al., 1995; Li et al., 2003). It has been suggested that GluN2B 
containing NMDARs are preferentially linked to cell death signaling pathways when 
compared with GluN2A containing NMDARs (Tu et al., 2010). Overexpression of the 
GluN2B subunit in HD mice has been shown to exacerbate HD-like pathology (Heng et 
al., 2009). In addition to subunit composition, the subcellular localization of NMDARs is 
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thought to play a pivotal role in determining whether the downstream intracellular 
signaling cascades promote cell-survival or stimulate cell death. This “localization 
hypothesis” posits that the activation of synaptic NMDARs promotes cell survival, while 
activation of extrasynaptic NMDARs promotes cell death (Hardingham et al., 2002). This 
hypothesis involves the concept that depending where in the cellular domain the receptor 
is located relative to the synapse, it will activate distinct downstream signaling cascades 
related to cell survival and plasticity, or cell death. A major outcome of synaptic NMDAR 
activation is increased phosphorylation and activity of an important transcriptional 
regulator CREB (Hardingham et al., 2001). Synaptic transmission promotes the 
expression of a multitude of anti-apoptotic, anti-oxidant, and pro-survival proteins 
including BDNF (Favaron et al., 1993; Hansen et al., 2004; Papadia et al., 2008). 
Conversely, increased extrasynaptic NMDAR expression, current, and associated 
reductions in CREB activation were observed in the striatum of YAC128 mice. In this 
case, extrasynaptic NMDAR activation promotes cell death (Milnerwood et al., 2010). 
Activation of extrasynaptic NMDARs results in CREB deactivation, release of apoptotic 
factors such as a result of mitochondrial calcium overload, and activation of cell death 
signaling p38 and c-JUN-N-terminal kinase-mitogen-activated protein kinases (JNK-
MAPKs);(Ivanov et al., 2006; Papadia et al., 2008; Hardingham and Bading, 2010; 
Parsons and Raymond, 2014). Furthermore, it has been suggested that GluN2B containing 
receptors are found predominately at extrasynaptic locations (Barria and Malinow, 2002). 
These findings suggest that glutamate release probability, receptor subcellular 
localization, and downstream signaling cascades are altered in the cortico-striatal system 
at an early age in HD (Milnerwood and Raymond, 2007).    
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1-8 Dysfunction of the hippocampus in prodromal Huntington Disease 
 Although aberrations in synaptic transmission are well documented in the cortico-
striatal system in prodromal HD, research surrounding early synaptic dysfunction in 
hippocampus is largely incomplete. There is however, some documented research 
classifying other types of deficits in the hippocampus of HD mice. Specifically, it was 
found that in newborn R6/2 mice, cell proliferation was compromised and granule cells 
had shorter apical dendrites, and DG neurons had a lesser degree of dendritic branching 
than in WT controls (Phillips et al., 2005). Furthermore, the number of BrdU+ cells, a 
marker that detects proliferating cells, was significantly decreased in the DG of R6/1 mice 
when compared to WT controls. Moreover, R6/1 mice had smaller and irregularly shaped 
cell-bodies, shorter dendrites, and migrated shorter distances into the granule cell layer 
when compared to WT controls (Lazic et al., 2006). Additionally, it was found that in 
symptomatic R6/2 mice, both synaptic plasticity and spatial cognition are impaired. 
Weakened coupling between excitatory post-synaptic potentials (EPSPs) and the 
generation of action potentials was observed. Additionally, in a Morris water maze task, 
R6/2 mice control mice swam back to the area of the removed platform while HD mice 
swam in a random manner with no reference to the platform’s location (Murphy et al., 
2000). It was also found that aggregation of neuronal intracellular inclusions, a hallmark 
of many polyglutamine repeat diseases, appear and increase with age in CA3, CA1, and 
DG of R6/2 HD mice (Morton et al., 2000). 
 In human studies, although sparse, there is evidence for prodromal hippocampal 
abnormalities. For example, hippocampal volume was reduced by up to 9% in a cohort of 
presymptomatic HD patients measured by high-resolution T1 weighted brain scans 
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(Rosas et al., 2003). In a TRACK-HD study examining early atrophy in a multitude of 
brain areas, hippocampal atrophy (up to 10% reduction in volume) was observed in 
“preHD-B” patients who were closer than 10.8 years to disease onset. TRACK-HD 
reports that early atrophy of the hippocampus rapidly becomes more severe as the disease 
moves into manifest stages and correlates with clinical measures (Bogaard et al., 2011). 
In another study, researchers employed techniques previously used in mouse models of 
HD to presymptomatic HD patients. Here, patients had to learn the location of a 
submerged hidden platform relative to external cues on the wall in a virtual Morris water 
maze task. Patients in the prodromal stage of HD were unable to learn the location of the 
platform as quickly as age-matched controls (Begeti et al., 2016). 
 Hippocampal dysfunction in the early to late onset stages of HD, in both animal 
and human studies, has been reported but hippocampal dysfunction in the HD prodrome 
is still widely understudied. In order to make progress in the pursuit to ameliorate HD, 
more in-depth investigation of the prodromal hippocampus is required. To begin more 
thorough investigation of the presymptomatic HD hippocampus, more sensitive pre-
clinical techniques may help to identify early deficits and help to develop more targeted 
therapeutics for the disease. There has been evidence showing that early intervention can 
delay or reverse HD progression. For example, low-dose treatment with the weak 
NMDAR antagonist memantine from 2 months of age reversed neuropathological and 
behavioural deficits in YAC128 mice when assessed at 12 months (Okamoto et al., 2009). 
Although deficits in the presymptomatic phase are not severe enough to require treatment, 
it is well known that early synaptic deficits are a prerequisite for cell death, thereby 
intervening early on in disease progression may allow for the slowing or cessation of cell 
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death later on in disease progression (Milnerwood and Raymond, 2010). For the purposes 
of this thesis, we employ multi-electrode array electrophysiology in order to investigate 
the electrophysiological properties of a large area of the hippocampus simultaneously. We 
also employ super-resolution microscopy to investigate nanoscale changes in synaptic 
architecture in the presymptomatic HD hippocampus.  
1-9 Multi-electrode array electrophysiology  
 When examining heterogenous cell populations like those that makeup the 
hippocampal formation, understanding how these cells function together as a whole can 
be pivotal to gaining further insight into how a brain area operates in both healthy and 
diseased brains. One method for examining the electrical properties and functional 
connectivity of large cell populations is microelectrode array electrophysiology. 
Application of microelectrode arrays (MEAs) to acute brain tissue was first reported 
when it was shown that an array could both stimulate and record from multiple sites on 
hippocampal slice preparations (Novak and Wheeler, 1988). Based on these findings, a 
more sophisticated MEA with a larger area and more effective hydrophilic electrode 
coating was developed (Oka et al., 1999). This MEA, known as the MED system, was the 
earliest version of the MEA used to investigate synaptic deficits in HD for this thesis. 
Although many other MEAs exist, the MED system offers proficiency in recording brain 
activity from multiple areas simultaneously.  
Although there is a substantial gap in the literature surrounding presymptomatic 
synaptic deficits in HD, and virtually no research in this area utilized MEAs, the MED 
system has been used to investigate cellular anomalies in hippocampus in other 
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neurodegenerative diseases such as Alzheimer Disease (AD). Here, researchers utilized 
the MED64 system to record field EPSP (fEPSP) deficits in the hippocampus of AD mice 
(Wang et al., 2018). Furthermore, the MED64 system was used to detect LTP deficits in a 
double transgenic model (5XFAD) of AD (Zhen et al., 2017). Furthermore, it was found 
utilizing the MED64 system that overexpression of cancerous inhibitor of PP2A (CIP2A), 
PP2A being a phosphatase known to play a key role in tau hyperphosphorylation in AD, 
led to a significant impairment of LTP at the Schaffer collateral synapse (Shentu et al., 
2018). Although the argument could be made that similar results as described above could 
be achieved via conventional electrophysiological techniques, having the ability to record 
from multiple sites across a heterogenous population of cells can offer insight into how 
these cell groups are collectively affected in a disease state, thus increasing the potential 
develop targeted pharmacological intervention for specific cell populations in these 
conditions. Therefore, the present thesis used MEA electrophysiology, namely the 
MED64 system, to examine synaptic transmission in the hippocampus, and more 
specifically to detect the earliest synaptic deficits detectable in the Q175FDN mouse 
model of HD.    
1-10 Super-resolution imaging 
For hundreds of years, light microscopy has helped researchers to understand the 
precise function of cells. For example, approximately 300 years ago Antoine Van 
Leeuwenhook used his self-ground optical lenses to discover bacteria and kickstart the 
field of microbiology. About 200 years after that, Ramon y Cajal used light microscopes 
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to investigate Golgi stained brains and create drawings of neurons and hypotheses 
surrounding information flow in the CNS (Huang et al., 2010).  
Unfortunately, the resolution for optical microscopy is limited by the diffraction 
or “spreading out” of light when it passes through a small aperture or is focused on a very 
small area. Due to the fact that this property is intrinsic to all light waves, breaking this 
diffraction barrier has been deemed impossible until recent super resolution microscopy 
techniques were developed (Huang et al., 2010). Recently, several novel fluorescence 
microscopy techniques have greatly surpassed the diffraction limit of image resolution. In 
general, all of these approaches generate diffraction unlimited images by using the 
physical properties of fluorescent probes to differentiate light emission from two nearby 
molecules that are within the diffraction limit. Although it is outside the scope of this 
thesis to go into each technique with immense detail, some examples of these techniques 
are: stimulated emission depletion (STED);(Klar and Hell, 1999), structured illumination 
microscopy (SIM);(Klar et al., 2000), stochastic optical reconstruction microscopy 
(STORM);(Rust et al., 2006), and photoactivated localization microscopy 
(PALM);(Betzig et al., 2006). Although these techniques are revolutionary and extremely 
efficient, they often come with fiscal setbacks and complicated optical setups that are not 
attainable for the average neuroscience research lab.  
Recently however, a new super resolution microscopy technique has been 
introduced that can be utilized with virtually any conventional wide-field microscope. 
This technique, known as super resolution radial fluctuation (SRRF), is executed via an 
open source ImageJ plugin that is capable of achieving spatial resolutions of up to 50 nm 
(Gustafsson et al., 2016). SRRF follows similar principles to STORM but generates a 
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super resolution reconstruction with the use of a series of images obtained from wide-
field microscopy, conventional fluorophores, and low-intensity illumination (Gustafsson 
et al., 2016). In neuroscience, the appeal of super resolution imaging stems from 
investigation of the synapse and its nanoarchitecture. The average synaptic cleft ranges 
from 20-50 nm in size (Bergles et al., 1997), indicating that conventional fluorescence 
imaging of the synapse would be limited by the intrinsic diffraction limit of light. 
However, application of super resolution imaging techniques allows researchers to 
investigate the nanoarchitecture of the synapse and its associated proteins and transporters 
to gain more in-depth insight into the structure and function of the synapse in both 
healthy and diseased brains. The present thesis uses super-resolution imaging, specifically 
SRRF, to investigate synaptic architecture at the nanoscale level in pre symptomatic 
Q175FDN HD mice.  
1-11 Hypothesis and aims  
Despite clear evidence of early cognitive decline in HD, few studies have 
identified cellular/synaptic dysfunction in the prodromal HD hippocampus. This is likely 
due to previous techniques and methodology not being able to achieve the level of 
sensitivity required to study these dysfunctions underlying early cognitive decline. 
Aberrations in synaptic transmission detected via multielectrode array electrophysiology, 
in combination with changes in synaptic nanoarchitecture elucidated through novel super 
resolution fluorescent imaging techniques could provide much-needed insight into the 
cognitive deficits associated with prodromal HD. 
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I hypothesize that synaptic transmission in the hippocampus is significantly 
altered in presymptomatic HD mice when compared to WT littermate controls. 
Specifically, I expect to see an impairment and possible failure of LTP in the 
hippocampus of presymptomatic HD mice. Furthermore, I hypothesize that super-
resolution imaging after cLTP will be sensitive to detect subtle alterations in synaptic 
architecture, namely the size, number, and the fluorescence intensity of protein clusters 
(nano-objects) in HD mice when compared to WT littermate controls. I expect that there 
will be basal differences in synaptic architecture between HD mice and WT controls, and 
these differences will be further exemplified when both genotypes undergo a plasticity 
(cLTP) protocol. I will investigate these hypotheses using the following specific aims:  
• Specific aim 1: Characterize LTP using MEA electrophysiology in 3-
month old Q175FDN HD mice and WT littermate controls.  
• Specific aim 2: Investigate pre and post synaptic nanoarchitecture in 3-
month old Q175FDN HD mice and WT littermate controls in both basal 
and LTP conditions by utilizing super resolution fluorescence microscopy, 
specifically SRRF. 
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2-0 Methods 
2-1 Animals 
All experiments were performed on acute brain slices obtained from male and female 
heterozygous Q175FDN mice (het), as well as wild-type littermates (WT). Breeder mice 
were obtained from University of British Columbia (UBC) and the colony was 
subsequently bred at Memorial University’s animal care facility. Mice were group-housed 
in ventilated cage racks, were provided with standard chow and water ab libitum, and 
were maintained on a normal 12 hour light/dark cycle. All experimental procedures were 
approved by Memorial University’s Institutional Animal Care Committee and were 
performed in accordance with the guidelines set by the Canadian Council on Animal 
Care.  
2-2 Slice preparation 
At 3 months of age ( 14 days), mice were anesthetized with isoflurane and 
decapitated, and the brain was quickly removed and immersed in ice-cold oxygenated 
(95% O2/5% CO2) slicing solution consisting of (in mM) 125 NaCl, 2.5 KCl, 25 
NaHCO3, 1.25 NaH2PO4, 2.5 MgCl2, 0.5 CaCl2, and 10 glucose. Transverse brain slices 
at 350 m containing hippocampus were obtained with a Leica VT1000 vibratome. Slices 
were then placed in artificial cerebrospinal fluid (aCSF) containing (in mM) 125 NaCl, 
2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, and 10 glucose. Slices were 
recovered in oxygenated aCSF for 90 min at room temperature before 
electrophysiological experimentation and for 180 min at room temperature before c-LTP 
protocol.  
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2-3 Multi-electrode array electrophysiology 
Slices were transferred to the recording chamber of the MED64 system (Alpha 
MED Scientific), known as the MED probe. The MED probe contains multiple 
microelectrodes embedded in the center of a transparent glass plate. For our experiments, 
we utilized the MED-RG501A probe (2x8 microelectrode array; 16 total electrodes) and 
the MED-R515A probe (8x8 microelectrode array; 64 total electrodes). Each electrode is 
10 mm in depth, and they are each 300 µm apart. Average input impedance of the 
electrodes is 100 MΩ. The surface of the MED probe was treated with 0.1% 
polyethylenimine, a cationic polymer, in 0.15 M borate buffer, pH 8.4, overnight at room 
temperature. The majority of materials that make up the MED probe are hydrophobic. To 
counteract this, coating the probe with a hydrophilic buffer allowed the tissue to sit near 
the electrodes. The probe surface was subsequently rinsed 3 times with sterile distilled 
water to remove the buffer. A peristaltic pump (Gilson Minipuls 3) was used to perfuse 
oxygenated (95% O2 / 5% CO2) aCSF to the probe containing the slice at a flow rate of 2 
ml/min. aCSF was maintained at 23C using an in-line heater and temperature controller 
(MED-CP04). One side of the acute hippocampal slice was adhered to the multi-electrode 
array by placing a small rectangular mesh, and a metal harp on the opposite side of the 
slice. If no response was elicited from one side, the slice was flipped in an attempt to 
elicit a response from that side.  
The stimulating electrode was selected in relation to its position in the Schaffer 
collateral pathway within the stratum radiatum. Mobius software (Alpha Med Scientific) 
was used to send triggering stimulus through the digital outputs of MED64 main and head 
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amplifiers (MED-A64MD1A/ MED-A64HE1S) for precise control over stimulating and 
recording via the 64-electrode array. Basal field potential responses were evoked using 
basal stimulation (stimulation intensity was manipulated until it evoked 30-40% of the 
maximal response during input-output (I/O)) at 20s intervals and simultaneously recorded 
at 63 (8x8 electrode), or 15 (2x8 electrode) sites until a minimum of 10 minutes of 
stability were achieved.  
Upon achieving a stable baseline, the MED64 system was utilized to deliver 
tetanic stimulation to induce LTP. Two different tetanic stimulation paradigms were used 
to induce different forms of LTP. HFS (1s at 100 Hz) and TBS (10 bursts of 4 pulses at 5 
Hz with each burst consisting of 4 pulses at 100 Hz). After tetanic stimulation, slices were 
continued to be perfused with aCSF for 60 minutes, while reverting back to basal 
stimulation evoking responses via single pulses every 20 seconds to measure changes 
induced by LTP. “%LTP” was defined as average of responses from 55-60 minutes post-
tetantic stimulation and was then expressed as an average percentage of the 10 minute 
baseline period. 
2-4 Chemical-LTP  
cLTP was induced in brain slices from 3-month old heterozygous Q175FDN HD mice, as 
well as WT littermates. cLTP protocol was based on previous work in stratum radiatum 
where LTP was induced chemically (Lin et al., 2008; Makino and Malinow, 2009; Zhou 
et al., 2018). Here, we chose to use cLTP over electrical stimulation so that we could 
induce LTP in the entire acute slice and then follow the necessary steps to visualize 
changes via fluorescence microscopy. cLTP was induced by bathing 350 m acute slices 
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for 10 minutes in 0-Mg2+ aCSF containing (in mM) 125 NaCl, 2.5 KCl, 25 NaHCO3, 
1.25 NaH2PO4, 2 CaCl2, and 10 glucose, followed by a 3 minute incubation in 0-Mg2+ 
aCSF combined with 200 M glycine. Slices were then transferred to a recovery well 
containing regular aCSF for 10 minutes. Control slices were also bathed in 0-Mg2+ aCSF 
for 10 minutes followed by regular aCSF for 3 minutes, and then transferred to another 
well containing regular aCSF for 10 minutes to follow the same experimental 
manipulation (sham) as the chemical-LTP treated slices except for glycine. Both cLTP 
and control slices were oxygenated throughout the entire experimental procedure. 
Following treatment, slices were subjected to immunohistochemistry (IHC) and 
subsequent super-resolution imaging.  
2-5 Immunohistochemistry 
 Immediately following the recovery period of the cLTP protocol, slices were 
fixed by immersion in 4% paraformaldehyde overnight at 4C and then cryoprotected in 
30% sucrose for a minimum of 24 hours. The acute slices were re-sectioned (16 µm) with 
a cryostat (Leica CM3050 S);(-23C) and placed on glass slides (Fisherbrand Superfrost 
Plus 1.0 mm) and stored at -80C for long-term storage if slides were not utilized right 
away. Slides were then retrieved from -80C and warmed at 37C on a slide warmer for 
20 minutes. While warming, a Dako pen (S2002, Dako Denmark, Denmark) was used to 
draw a hydrophobic barrier around sections of the slide to contain the antibodies once 
they were applied. Following this, the slides were washed in 0.01M PBS for 5 minutes. 
This step was repeated for a total of three times.  
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Slides were then incubated in blocking serum (0.01M PBS with 5% BSA) for 1 
hour. After blocking, slides were incubated in primary antibody (rabbit monoclonal anti-
GluA2, 1:500, Neuromab) overnight at 4C. On day two, slides were incubated in 
secondary antibody (Alexa fluor 488-conjugated goat anti-rabbit IgG 1:500, Life 
Technologies Corporation) at room temperature for 2 hours. All remaining procedures 
were carried out in opaque slide holders as well as in reduced lab lighting to prevent 
photobleaching of the secondary antibody fluorophores. Next, slides were blocked with 
blocking solution containing Triton X-100 (0.25%) for 1 hour at room temperature to 
permeabilize the cell membrane and allow antibody penetration into the cell. Slides were 
then incubated in another primary antibody (rabbit monoclonal anti-Synaptophysin, 
1:1000, Abcam,) overnight at 4C. On day 3, the slides were washed three times in PBS 
and then incubated in a secondary antibody (Alexa fluor 594-conjugated goat anti-mouse 
1:500, Life Technologies Corporation) at room temperature for 2 hours. Finally, slides 
were cover-slipped using Dako mounting medium containing DAPI. Once dry (1-2 days 
storage at room temperature), slides were transferred to a slide box and placed in 4C for 
long-term storage. To control for variation in staining intensities, all 
immunohistochemistry was carried out in one batch.  
2-6 Super-resolution imaging  
 Imaging of CA1 stratum radiatum hippocampus of re-sectioned (16 µm) mouse 
hippocampal slices was performed using an EM-CCD camera (Andor, iXon Ultra 897, 
DU-897U-CSO-#BV) and Olympus BX51 microscope. Precise control of LED 
illumination source (Prior, Lumen 300) was controlled manually by switching the LED 
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illumination source on and off when needed. The region of interest (ROI) was identified 
and selected through a 4x objective (Olympus, 0.28NA) to ensure a wide-field view of the 
slice and specifically the Schaffer collateral pathway. Furthermore, one ROI was selected 
at a proximal area of CA1 (approximately 150-450 µm from CA3 cell bodies) and one 
was selected from a distal area of CA1 (approximately 500-800 µm from CA3 cell 
bodies). Once the ROI was selected, a 60x objective (Olympus, 1.40NA) was positioned 
to capture the images required for super-resolution imaging. 60x imaging was completed 
through an objective that required oil immersion (Zeiss, Immersol 518F, Batch no: 
170704). Images were acquired with Ander Solis software, capturing 100 images over 
approximately 10 seconds, to yield a final super-resolution image. Acquisition settings 
were as follows: Exposure time, 0.1s; number of accumulations, 1; accumulation cycle 
time, 0.118s (8.45 Hz); kinetic series length, 100; kinetic cycle time, 0.118s (8.45 Hz); 
shift speed, 0.3; vertical clock voltage amplitude, normal; readout rate, 17MHz at 16-bit; 
pre-amplifier gain, gain 1; output amplifier, electron multiplying; electron multiplier gain 
level, 2. Standard filter cubes were used for GFP and mCherry to yield green and red 
images, respectively.   
2-7 Experimental design and statistics.  
The statistical tests used include: one-way ANOVA, one-way repeated measures 
(RM) ANOVA, two-way ANOVA, linear regression, and T-test. Post hoc tests included 
Tukey, Bonferroni and Dunnett tests. The statistical test used for each experiment is 
stated within the results section. P values of < 0.05 were considered significant. Where 
indicated, “N” and “n” refer to the number of animals and slices used in each experiment, 
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respectively. Furthermore, bilinear interpolation via ImageJ was used to create the 2-
dimensional plots of hippocampal LTP. 
Super resolution images were analyzed using the “NanoJSRRF” plugin in Fiji 
(Fiji is just ImageJ). The analysis was completed in an automated series of steps in Fiji. 
Initially, the 512x512 series of 100 images were cropped to 128x128 (equivalent to a field 
of view of 34x34 µm). Next, a drift correction (to increase resolution and correct for 
fluorophore fluctuation across images during acquisition) was completed. Next, this 
cropped series of images was run through the NanoJSRRF plugin, creating a super-
resolution image. In conjunction with SRRF analysis, chromatic aberration correction (to 
correct for the tendency of a lens to erroneously focus colors to different points) was 
performed. At this point, the colour of the images was changed to reflect their respective 
fluorophores with GluA2 images being converted to green and Synaptophysin (SYN) to 
red. Furthermore, these images were merged to create a composite image for 
representative purposes. The corrected individual images (GluA2 & SYN) were then 
converted to 8-bit (binary) in order to run auto local thresholding to separate puncta from 
background information. Specifically, “Bernsen” auto local thresholding was determined 
to reflect to most accurate puncta cut-off measures for the specific antibodies utilized for 
the purposes of this thesis. Bernsen’s local thresholding method is a form of binarization 
commonly used for image segmentation for converting grayscale images to binary. From 
this binary image, Fiji generated a list of the puncta in each image while simultaneously 
measuring the area of each puncta, allowing us to determine puncta size. This list of 
puncta was then overlaid onto the original SRRF image, where Fiji determines the mean 
fluorescent intensity of each puncta based on the chromatic properties. Furthermore, 
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puncta density was determined by dividing the number of puncta per image by the area of 
the image (34x34 µm).  
Nearest Neighbor (NN) analysis was carried out via Nano-J Core “Nearest 
Neighbor” analysis to generate Voronoi plots and an excel spreadsheet generated by the 
Parsons lab for numerical NN analysis. Specifically, this NN analysis determined the 
exact center (centroid) of each GluA2 puncta and subsequently measured its distance 
from the centroid of the nearest SYN puncta to measure any changes in protein position 
amongst the different conditions. NN analysis via Nano-J Core also generated Voronoi 
diagrams to visualize puncta distance for representative purposes. From this, it was 
possible to determine where puncta were located based on their corresponding distances 
from one another.   
2-8 N-values  
 For electrophysiological experiments “N” refers number of animals used in the 
experiment, and “n” refers to number of acute slices. For super resolution (SRRF) 
experiments, “N” refers to number of animals, “n” refers to number of acute slices, “n1” 
refers to number of 16 µm resections, and “n2” refers to number of nano-objects analyzed.   
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3-0 Results 
3-1 Increased basal transmission in the hippocampus of presymptomatic Huntington 
disease mice revealed using multi-electrode array electrophysiology 
 The phenotypic presentation of a wide array of neurodegenerative disease are 
often rooted in deficits in synaptic trasmission and LTP (Selkoe, 2002). Cellular 
disturbances are well characterized in HD. For example, neurotransmitter release 
probability, receptor subcellular localization and/or downstream signaling cascades are 
altered in the cortico-striatal system at an early age in HD mice (Milnerwood and 
Raymond, 2007; Milnerwood et al., 2010; Parsons and Raymond, 2014). However, in 
order to understand LTP and its mechanisms in HD, we first need to investigate basal 
transmission to fully understand communication at the synapses of interest. One prior 
study showed no significant difference in I/O curves between WT and HD mice at the 
Schaffer collateral synapse (Usdin et al., 1999); however, a more recent investigation 
found increased basal connectivity (i.e. larger I/O responses) in R6/2 mice at 6 weeks of 
age (Beaumont et al., 2014). Here, to determine whether any basal differences in synaptic 
transmission exist between WT and Q175FDN HD mice, we examined the I/O 
relationship of hippocampal Schaffer collateral synapses in response to increasing 
stimulus intensity of single electrical stimuli. As expected, there was a significant effect 
of stimulus intensity on the response size, where the slope of fEPSCs grew larger as the 
stimulus intensity increased at every location examined. At 150 µm away from the 
stimulating electrode (see fig.2 for MEA schematic), there was no significant effect of 
genotype and no significant interaction effect was observed. (fig. 3a), RM two-way 
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ANOVA, p(stim intensity) < 0.001, p(genotype) = 0.354, p(interaction) = 0.462, WT: n=17, Het: 
n=18). At 300 µm, while there was no significant genotype effect, we did observe a 
significant interaction effect, reflecting the larger fEPSP to higher stimulus intensities in 
heterozygous mice (fig. 3b, RM two-way ANOVA, p(genotype) = 0.354, p(stim intensity) < 0.001, 
p(interaction) = 0.003, WT: n=17, Het: n=18). At 450 µm, similar to 300 µm, a significant 
interaction effect was observed. Interestingly, at this distance, a significant genotype 
effect emerged, with mean fEPSP being larger in heterozygous mice compared to WT 
littermates (fig. 3c, RM two-way ANOVA, p(genotype) = 0.025, p(stim intensity) < 0.001, 
p(interaction) <0.001, WT: n=17, Het: n=18). At 600 µm, the significant effect of genotype 
was no longer apparent, although a significant interaction effect was again observed (fig. 
3d, RM two-way ANOVA, p(genotype) = 0.054, p(stim intensity) < 0.001, p(interaction) < 0.001, WT: 
n=17, Het: n=18). Finally, at 750 µm, there was no significant effect of genotype and the 
significant interaction effect noted at other distances was no longer observed (fig. 3e, RM 
two-way ANOVA, p(genotype) = 0.426, p(stim intensity) < 0.001, p(interaction) = 0.856, WT: n=17, 
Het: n=18). These data are indicative of a clear difference in basal transmission between 
WT and HD mice at specific distances along stratum radiatum in the hippocampus. 
Increased basal excitatory transmission is observed in the HD hippocampus. The 
discrepancies from previous research reporting either no change (Usdin et al., 1999) or in 
agreement showing an increase (Beaumont et al., 2014) in basal transmission may stem 
from the precise location of the recording electrode within the stratum radiatum. 
Recently, it has been established that there is a high level of heterogeneity amongst cell 
populations in the hippocampus, with some transcriptional heterogeneity observed along 
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the proximal-distal axis (Cembrowski et al., 2016). These varying results may reflect the 
heterogeneity found across the long axis of hippocampus (Cembrowski et al., 2016).    
 To help visualize how I/O responses varied from proximal to distal recording sites 
within each genotype, I/O data were also grouped into two graphs, one each for WT and 
het, displaying the evoked response differences across stratum radiatum (fig. 4). Here, 
WT mice showed a significant effect of stimulus intensity, electrode position, and a 
significant interaction (fig. 4a, RM two-way ANOVA, p(stim intensity) < 0.001, p(position) < 
0.001, p(interaction) < 0.001, n=17). These results held true for the heterozygous group (fig. 
4b, p(stim intensity) < 0.001, p(position) = 0.007, p(interaction) < 0.001, n=18). Here, these results 
display the decrease in basal synaptic transmission in both genotypes as stimulation 
propagates along the proximal-distal axis of hippocampus. 
 In summary, while examining basal synaptic transmission along the proximal-
distal axis of hippocampus in WT and heterozygous mice, we observed an increase in 
synaptic transmission in the heterozygotes which became more apparent in the medial-
distal areas (300-600 µm) of the Schaffer collateral pathway of hippocampus. These 
results are indicative of clear aberrant basal synaptic signaling in the presymptomatic HD 
mice.  
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Figure 2: Schematic of MEA (MED64) hippocampal acute slice placement on to 
electrode array. 
Representative image of an acute slice from a Q175FDN mouse adhered to a MED64 8x8 
electrode array, with the hippocampus positioned directly on to the array. The electrodes 
are arranged in a grid with 150 µm distance between neighboring electrodes. Orange 
arrow and circle represent typical location of stimulation electrode, purple arrow and 
circle represent typical proximal recording site (300 µm), red arrow and circle represent 
typical distal recording site (750 µm). Electrode immediately to the left of the purple 
circle represents typical site for 150 µm, electrodes immediately to the right of the purple 
circle represents typical recording site at 450 µm, and electrodes immediately to the left 
of the red circle represents typical recording site at 600 µm. 
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Figure 3: Input-Output (I/O) responses across stratum radiatum in WT and 
heterozygous mice.  
(A) I/O graph displaying the slope of evoked fEPSP (field excitatory post-synaptic 
potential) response over stimulus intensity for the recording electrode 150 µm (toward 
CA1) away from the stimulating electrode. (B) I/O graph displaying slope of evoked 
EPSP response over stimulus intensity for the recording electrode 300 µm away from the 
stimulating electrode. (C) I/O graph displaying slope of evoked EPSP response over 
stimulus intensity for the recording electrode 450 µm away from the simulating electrode. 
(D) I/O graph displaying slope of evoked EPSP response over stimulus intensity for the 
recording electrode 600 µm away from the stimulating electrode. (E) I/O graph 
displaying slope of evoked EPSP response over stimulus intensity for the recording 
electrode 750 µm away from the stimulating electrode. WT displayed in purple, Het 
displayed in pink. 
*p<0.05, *** p<0.005 
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Figure 4: Input-Output (I/O) relationship within genotype across stratum radiatum.  
(A) I/O relationship at each recording electrode across the proximal-distal axis of 
hippocampus for WT mice. (B) I/O curves displaying each electrode across the proximal-
distal axis of hippocampus for Het mice. 150 µm away from the stimulating electrode in 
red, 300 µm away in orange, 450 µm away in purple, 600 µm away in green, and 750 µm 
away in black. 
**p<0.01, ***p<0.001 
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3-2 Deficits in hippocampal synaptic plasticity in presymptomatic Huntington 
disease mice revealed using multi-electrode array electrophysiology.  
 Synaptic deficits including alterations in paired-pulse facilitation, AMPAR- and 
NMDAR-mediated synaptic transmission, and glutamate release are well documented in 
the striatum of both prodromal and symptomatic HD (Klapstein et al., 2001; Starling et 
al., 2005; Joshi et al., 2009; Parsons et al., 2016). Cellular deficits such as reduced 
dendritic spine size, deficits in cell proliferation, and weakened “gain” or coupling 
between EPSPs and action potentials (Murphy et al., 2000; Phillips et al., 2005; Lazic et 
al., 2006) have been characterized in the hippocampus of early HD. However, there 
remains a substantial gap in the literature with respect to the earliest aberrations in 
hippocampal synaptic transmission in presymptomatic HD.  
Here, in an attempt to detect some of the earliest synaptic aberrations with 
putative relevance to the early cognitive deficits observed in HD patients (Tabrizi et al., 
2009), we utilized a highly sensitive electrophysiological paradigm in the MED64 system 
(Oka et al., 1999).The MED64 system was used to examine activity-dependent synaptic 
plasticity in presymptomatic HD mice via two well-established LTP induction paradigms, 
HFS and TBS. It has been shown in the hippocampus that successful LTP consolidation 
by these two induction paradigms occurs via distinct mechanisms. Specifically, TBS-LTP 
requires activation of calpain-1 and extracellular signal regulated kinases (ERK), while 
HFS-LTP relies on protein-kinase A (PKA) phosphorylation and does not require ERK 
activation (Selcher et al., 2003; Zhu et al., 2015).  
In these experiments, the slope of the fEPSP was measured and LTP was defined 
as a slope at least 20% larger than baseline that sustained for 60 minutes. Slices from 3-
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months old WT and het mice that received HFS-LTP was observed across stratum 
radiatum as expected (fig. 5). However, no significant differences were detected between 
WT (N=5, n=10) and heterozygous (N=5, n=9) mice delivered HFS-LTP with respect to 
genotype, recording electrode position relative to the stimulating electrode, or interaction 
(fig. 5 a-f) (RM two-way ANOVA, p(genotype) = 0.740, p(position) = 0.170, p(interaction) = 0.682). 
Bonferroni post-hoc tests p > 0.05 for all positions. Specifically, at 150 µm WT HFS-LTP 
was 44.1 ± 6.50 % of baseline values and het HFS-LTP was 45.1 ± 12.1% (t-test, p = 
0.950). At 300 µm, WT HFS-LTP was 44.6 ± 6.00% and het HFS-LTP was 48.0 ± 12.0% 
(t-test, p = 0.814). At 450 µm, WT HFS-LTP was 50.6 ± 6.00% and het HFS-LTP was 
44.5 ± 10.0% (t-test, p = 0.630). At 600 µm, WT HFS-LTP was 41.1 ± 11.4% and het 
HFS-LTP was 32.5 ± 8.80% (t-test, p = 0.552). At 750 µm, WT HFS-LTP was 42.6 ± 
10.5% and het HFS-LTP was 39.9 ± 8.10% (t-test, p = 0.463). To better visualize the 
effect of HFS on fEPSC amplitude LTP throughout the stratum radiatum, we used 
bilinear interpolation (ImageJ) to generate 2D heatmaps that display the magnitude of 
synaptic responses at 55-60 minutes post-tetanic stimulation across the electrodes that 
were located in stratum radiatum (fig. 5g). These heatmaps provide a visual of the results 
described above by displaying low %LTP in cool colours (black/blue) and high %LTP in 
warm colours (red/yellow/orange) to topographically describe the LTP observed. These 
data indicate that HFS-LTP is unaffected at 3 months in this model of HD. 
Interestingly, and in stark contrast to HFS, brain slices from 3-month old het mice 
that were delivered TBS showed significant impairments of LTP compared to age-
matched WT at electrodes distal to the stimulating electrode, and a significant interaction 
effect was observed (fig. 6);(WT N=4, n=7, het N=5, n=9; RM two-way ANOVA, 
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p(genotype) = 0.058, p(position) = 0.005, p (interaction) = 0.029). Specifically, at 150 µm WT TBS-
LTP was 55.9 ± 6.80% and het TBS-LTP was 57.6 ± 10.2% (t-test, p = 0.897). At 300 
µm, WT TBS-LTP was 60.6 ± 8.00% and het TBS-LTP 38.3 ± 10.6% (t-test, p = 0.133). 
At 450 µm, WT TBS-LTP was 66.5 ± 10.6% and het TBS was 33.4 ± 7.40% (t-test, p = 
0.02). At 600 µm, WT TBS-LTP was 55.2 ± 10.6% and het TBS was 23.4 ± 7.80% (t-
test, p = 0.03). Finally, at 750 µm, WT TBS-LTP was 41.5 ± 7.70% and het TBS-LTP 
was 21.6 ± 6.50% (t-test, p = 0.06). These data indicate that functional impairments of 
excitatory synapses in the hippocampus exist at presymptomatic stage of HD. While there 
were statistically significant deficits in TBS-LTP, no apparent deficits in HFS-LTP were 
found. These results suggest that the signaling pathways involved in the consolidation of 
TBS-LTP may be affected earlier in the time course of the disease than those involved in 
HFS-LTP consolidation in the HD hippocampus.  
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Figure 5: HFS induces similar LTP across stratum radiatum in WT and 
heterozygous mice. 
(A) LTP in WT (purple) and Het (pink) mice at 150 µm away from the stimulating 
electrode. In representative traces for panel A-E, black trace represents fEPSPs before 
LTP induction and red trace represents fEPSP recorded 55-60 minutes after LTP 
induction. HFS was applied to all electrodes at time 0. (B) LTP in WT and Het at 300 µm 
away from the stimulating electrode. (C) LTP in WT and Het at 450 µm away from the 
stimulating electrode. (D) LTP in WT and Het at 600 µm away from the stimulating 
electrode. (E) LTP in WT and Het at 750 µm away from the stimulating electrode. (F) % 
change in fEPSC slope from baseline in the last 5 minutes of the experiment (minute 55-
60) in WT and Het at each electrode. (G) 2D heatmap generated by bi-linear interpolation 
of 16 electrodes of the MEA displaying %LTP across the stratum radiatum of 
hippocampus. “Stim” refers to the stimulating electrode site in the MEA. 
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Figure 6: TBS-LTP in stratum radiatium is impaired in heterozygous HD mice.  
(A) LTP in WT (purple) and Het (pink) mice at 150 µm away from the stimulating 
electrode. In representative traces for all panels, black represents pre-LTP induction and 
red represents 55-60 minutes post-LTP induction. (B) LTP in WT and Het at 300 µm 
away from the stimulating electrode. (C) LTP in WT and Het at 450 µm away from the 
stimulating electrode. (D) LTP in WT and Het at 600 µm away from the stimulating 
electrode. (E) LTP in WT and Het at 750 µm away from stimulating electrode. (F) %LTP 
increase from baseline in the last 5 minutes of the experiment (minute 55-60 post LTP) in 
WT and Het at each electrode. (G) 2D heatmap generated by bi-linear interpolation of 16 
electrodes of the MEA displaying %LTP across the proximal distal-axis of hippocampus. 
“Stim” refers to the stimulating electrode site in the MEA. 
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3-3 Super-resolution radial fluctuation (SRRF) imaging of GluA2 and 
Synaptophysin across the stratum radiatum in WT and Heterozygous mice.  
Until recently, visual investigation of the nanoarchitecture of the synapse using 
light microscopy was hindered by the intrinsic diffraction barrier of light as it passes 
through a small aperture or is focused on a very small area (Huang et al., 2010). However, 
novel techniques in microscopy have been developed to surpass this diffraction barrier, 
allowing imaging and investigation of nano-objects that exist beyond the approximate 
200 nm diffraction limit of light microscopy. Due to the novel nature of these techniques, 
synaptic nanoarchitecture has not been widely studied in HD brains. From our MEA 
electrophysiology results, we determined that aberrations in synaptic transmission, 
specifically in LTP induced by physiologically relevant stimulus (TBS), are apparent in 
presymptomatic HD mice. Though these findings are novel and intriguing, MEA 
electrophysiology only samples synaptic responses at the cell population level, and does 
not distinguish between functional and structural changes.  
In order to probe the observed TBS-LTP anomaly further and investigate 
presymptomatic HD at the synaptic/subcellular level, we sought to bridge the gap 
between electrophysiological properties and subcellular level alterations in architecture 
by utilizing SRRF imaging techniques. In this study, we focused on two major proteins 
that constitute the excitatory synapse: the AMPAR receptor subunit GluA2 (fig. 7,8) and 
the pre-synaptic vesicular glycoprotein SYN (fig. 9,10) along the stratum radiatum. To 
investigate alterations in synaptic protein distribution associated with synaptic plasticity, 
subsets of acute hippocampal tissue from WT and HD mice underwent cLTP. We also 
further investigated GluA2 and SYN by utilizing a nearest neighbour (NN) analysis 
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paradigm to assess any changes in how the pre and post-synapatic architecture may 
change spatially with respect to one another in presymptomatic HD. Here, we examined 
the movement of clusters of GluA2 and SYN proteins known as nano-objects based on 
their nearest neighbour in WT control, WT cLTP, Het control, and Het cLTP tissue (fig. 
11,12).       
3-4 SRRF imaging of GluA2 in proximal stratum radiatum in WT and heterozygous 
mice.  
In proximal stratum radiatum (i.e. 150-450 µm away from CA3 cell bodies, fig. 3) 
we found a significant difference in GluA2 size between genotypes (fig. 7a,b);(one-way 
ANOVA, p < 0.001). More specifically, in basal conditions, Het GluA2 size was 
significantly larger than WT GluA2 size. As expected (Hruska et al., 2018), cLTP 
significantly increased GluA2 size in WT tissue. In contrast, cLTP resulted in a 
significant reduction in GluA2 size in hippocampal tissue obtained from HD mice (post-
hoc Tukey tests for WT control vs. WT cLTP, p < 0.001; WT control vs. Het control, p < 
0.001; WT control vs. Het cLTP, p < 0.001; WT cLTP vs. Het control, p < 0.001; WT 
cLTP vs. Het cLTP, p = 0.003; Het control vs. Het cLTP, p < 0.001; WT control: N=3, 
n=5, n1=10, n2=5869; WT cLTP: N=3, n=6, n1=12, n2=7003; Het control: N=3, n=6, 
n1=12, n2=7319; Het cLTP: N=3, n=6, n1=12, n2=6758). The decrease in size observed in 
Het tissue after cLTP was robust and is a complete reversal from what we observed in 
WT tissue.  
Changes in fluorescence intensity in super-resolution microscopy are often 
indicative of nanoscale reorganization (Huang et al., 2010), specifically clustering or 
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dispersing of nano-objects. Here, we observed a significant difference in GluA2 intensity 
between genotypes (Fig. 7c, one-way ANOVA, p < 0.001). More specifically, in basal 
conditions, Het GluA2 intensity was significantly lower than that in WT. Furthermore, 
cLTP induced a modest but significant reduction in GluA2 intensity in WT tissue. This 
observation in combination with the GluA2 size result indicates that larger puncta may 
represent more dispersed, and therefore less intense, nano-objects. Moreover, cLTP 
significantly increased GluA2 intensity in Het tissue. (post-hoc Tukey tests for WT 
control vs. WT cLTP, p = 0.008; WT control vs. Het control, p < 0.001; WT control vs. 
Het cLTP, p < 0.001; WT cLTP vs. Het control, p < 0.001; WT cLTP vs. Het cLTP, p < 
0.001; Het control vs. Het cLTP, p < 0.001; WT control: N=3, n=5, n1=10, n2=5869; WT 
cLTP: N=3, n=6, n1=12, n2=7003; Het control: N=3, n=6, n1=12, n2=7319; Het cLTP: 
N=3, n=6, n1=12, n2=6758). When measuring GluA2 density, which is indicative of the 
number of nano-objects per given area (fig. 7d, number of nano-objects per image) we 
found no significant difference in proximal areas of hippocampus (one way ANOVA, p = 
0.415; post-hoc Tukey tests for WT control vs. WT cLTP, p = 0.999; WT control vs. Het 
control, p = 0.870; WT control vs. Het cLTP, p = 0.842; WT cLTP vs. Het control, p 
=0.677; WT cLTP vs. Het cLTP, p = 0.948; Het control vs. Het cLTP, p = 0.353; WT 
control: N=3, n=5, n1=10; WT cLTP:N=3, n=6, n1=12; Het control: N=3, n=6, n1=12; Het 
cLTP: N=3, n=6, n1=12). From these results as a whole, it is apparent that there are basal 
differences in post-synaptic nanoarchitecture between WT and het tissue. Furthermore, 
after cLTP there are significant alterations in the nanoarchitecture of GluA2 in proximal 
areas of hippocampus. Specifically, it is evident that in WT tissue, cLTP causes GluA2 
puncta to increase in size (fig. 7b,e,f,g) in conjunction with a decrease in fluorescence 
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intensity (fig. 7c,h,i,j) with no overall change in the number of puncta (fig. 7d). However, 
in het tissue, cLTP causes GluA2 puncta to decrease in size while their corresponding 
fluorescence intensity decreases with no overall change in the number of puncta. These 
results indicate that there are significant alterations at a presymptomatic HD  in nanoscale 
organization of excitatory synapses in the hippocampus. 
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Figure 7: GluA2 expression before and after LTP induction in proximal stratum 
radiatum from WT and Het mice 
(A) Representative SRRF images in proximal stratum radiatum of GluA2 in all 
conditions. Top left: WT control, top right: WT cLTP, bottom left: Het control, bottom 
right: Het cLTP. (B) GluA2 size for all conditions. (C) GluA2 fluorescent intensity for all 
conditions. AU stands for arbitrary units. (D) GluA2 density (nano-objects/per µm2) for 
WT control, WT cLTP, Het control, and Het cLTP. (E) Cumulative frequency graph for 
GluA2 size comparing WT control and Het control tissue. (F) Cumulative frequency 
graph for GluA2 size comparing WT control and WT cLTP tissue. (G) Cumulative 
frequency graph for GluA2 size comparing Het control and Het cLTP tissue. (H) 
Cumulative frequency graph for GluA2 intensity comparing WT control and WT cLTP 
tissue. (I) Cumulative frequency graph for GluA2 intensity comparing WT control and 
WT cLTP tissue. (J) Cumulative frequency graph for GluA2 intensity comparing Het 
control and Het cLTP tissue. 
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3-5 SRRF imaging of GluA2 in distal stratum radiatum in WT and heterozygous 
mice. 
In distal stratum radiatum (i.e. 500-800 µm away from CA3 cell bodies), similar 
to proximal, we observed a significant difference in GluA2 size (fig. 8b);(one-way 
ANOVA, p < 0.001). More specifically, het control GluA2 size was significantly larger 
than WT control GluA2 size. Furthermore, cLTP significantly increased GluA2 size in 
WT tissue, while cLTP significantly reduced GluA2 size in het tissue (post-hoc Tukey 
tests for WT control vs. WT cLTP, p < 0.001; WT control vs. Het control, p < 0.001; WT 
control vs. Het cLTP, p < 0.001; WT cLTP vs. Het control, p < 0.001; WT cLTP vs. Het 
cLTP, p = 0.001; Het control vs. Het cLTP, p < 0.001; WT control: N=3, n=5, n1=10, 
n2=5921; WT cLTP: N=3, n=6, n1=12, n2=6514; Het control: N=3, n=6, n1=12, n2=6606; 
Het cLTP: N=3, n=6, n1=12, n2=6662). When measuring GluA2 fluorescent intensity (fig. 
8c), we found a significant difference (one-way ANOVA, p < 0.001). More specifically, 
het basal intensity was significantly decreased when compared to WT basal tissue. 
Furthermore, cLTP significantly reduced GluA2 intensity in WT tissue, while cLTP 
significantly increased GluA2 intensity in Het tissue. (post-hoc Tukey tests for WT 
control vs. WT cLTP, p = 0.001; WT control vs. Het control, p = 0.0019; WT control vs. 
Het cLTP, p < 0.001; WT cLTP vs. Het control, p < 0.001; WT cLTP vs. Het cLTP, p 
=9095; Het control vs. Het cLTP, p < 0.001; WT control: N=3, n=5, n1=10, n2=5921; WT 
cLTP: N=3, n=6, n1=12, n2=6514; Het control: N=3, n=6, n1=12, n2=6606; Het cLTP: 
N=3, n=6, n1=12, n2=6662). When measuring GluA2 density (fig. 8d, number of nano-
objects per area) we found no significant difference (one way ANOVA, p = 0.340; post-
hoc Tukey tests for WT control vs. WT cLTP, p = 0.999; WT control vs. Het control, p = 
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0.990; WT control vs. Het cLTP, p = 0.529; WT cLTP vs. Het control, p =0.968; WT 
cLTP vs. Het cLTP, p = 0.597; Het control vs. Het cLTP, p = 0.328 WT control: N=3, 
n=5, n1=10; WT cLTP: N=3, n=6, n1=12; Het control: N=3, n=6, n1=12; Het cLTP: N=3, 
n=6, n1=12). From these data, we can infer that after cLTP there are significant alterations 
in the nanoarchitecture of GluA2 in distal stratum radiatum. The similar changes that we 
observed in both proximal and distal areas of hippocampus in terms of size (fig. 8b,e,f,g), 
intensity (fig. 8c,h,i,j), and density (fig. 8d) are indicative of spatially sustained alterations 
of post-synaptic nanoarchitecture in the stratum radiatum of presymptomatic HD. 
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Figure 8: GluA2 expression before and after LTP induction in distal stratum 
radiatum from WT and Het mice 
(A) Representative SRRF images in distal stratum radiatum of GluA2 in all conditions. 
Top left: WT control, top right: WT cLTP, bottom left: Het control, bottom right: Het 
cLTP. (B) GluA2 size for all conditions. (C) GluA2 fluorescent intensity for all 
conditions. AU stands for arbitrary units (D) GluA2 density (nano-objects/per µm2) for 
WT control, WT cLTP, Het control, Het cLTP. (E) Cumulative frequency graph for 
GluA2 size comparing WT control and Het control tissue. (F) Cumulative frequency 
graph for GluA2 size comparing WT control and WT cLTP tissue. (G) Cumulative 
frequency graph for GluA2 size comparing Het control and Het cLTP tissue. (H) 
Cumulative frequency graph for GluA2 intensity comparing WT control and WT cLTP 
tissue. (I) Cumulative frequency graph for GluA2 intensity comparing WT control and 
WT cLTP tissue. (J) Cumulative frequency graph for GluA2 intensity comparing Het 
control and Het cLTP tissue.  
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3-6 SRRF imaging of synaptophysin in proximal stratum radiatum in WT and 
heterozygous mice. 
In proximal stratum radiatum (i.e. 150-450 µm away from CA3 cell bodies) when 
investigating SYN (fig. 9, we found a significant difference in SYN size (fig. 9b);(one-
way ANOVA, p < 0.001). More specifically, in basal conditions, het control SYN size 
was significantly larger than WT control SYN size. Furthermore, cLTP significantly 
reduced SYN size in het tissue but had no effect on WT tissue (post-hoc Tukey tests for 
WT control vs. WT cLTP, p = 0.688; WT control vs. Het control, p < 0.001; WT control 
vs. Het cLTP, p = 0.980; WT cLTP vs. Het control, p < 0.001; WT cLTP vs. Het cLTP, p 
= 0.385; Het control vs. Het cLTP, p < 0.001; WT control: N=3, n=5, n1=10, n2=5272; 
WT cLTP: N=3, n=6, n1=12, n2=6784; Het control: N=3, n=6, n1=12, n2=6588; Het 
cLTP: N=3, n=6, n1=12, n2=6050). The change in SYN size is indicative of a pre-synaptic 
alteration in nanoarchitecture of presymptomatic HD mice. Furthermore, we found a 
significant difference in SYN intensity (fig.10c, one-way ANOVA, p < 0.001). Firstly, 
there was no observed difference in basal intensity between WT and HD mice. cLTP 
significantly increased SYN intensity in both WT and Het tissue, however the increase in 
het tissue was not as large as the increase in WT tissue (post-hoc Tukey tests for WT 
control vs. WT cLTP, p < 0.001; WT control vs. Het control, p = 0.365; WT control vs. 
Het cLTP, p < 0.001; WT cLTP vs. Het control, p < 0.001; WT cLTP vs. Het cLTP, p < 
0.001; Het control vs. Het cLTP, p < 0.001; WT control: N=3, n=5, n1=10, n2=5272; WT 
cLTP: N=3, n=6, n1=12, n2=6784; Het control: N=3, n=6, n1=12, n2=6588; Het cLTP: 
N=3, n=6, n1=12, n2=6050). When measuring SYN density (fig. 9d, number of nano-
objects per image), similar to our GluA2 results, we found no significant difference 
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between genotypes or treatment conditions in proximal stratum radiatum (one way 
ANOVA, p = 0.275; post-hoc Tukey tests for WT control vs. WT cLTP, p = 0.979; WT 
control vs. Het control, p = 0.809; WT control vs. Het cLTP, p = 0.779; WT cLTP vs. Het 
control, p =0.954; WT cLTP vs. Het cLTP, p = 0.500; Het control vs. Het cLTP, p = 
0.231; WT control: N=3, n=5, n1=10; WT cLTP: N=3, n=6, n1=12; Het control: N=3, 
n=6, n1=12; Het cLTP: N=3, n=6, n1=12). Here, we surmise that after cLTP there are 
significant alterations in the puncta properties of SYN in relation to size (fig. 9b,e,f,g) and 
intensity (fig. 9c,h,i,j), suggesting pre-synaptic alterations. Distinct changes were found in 
nanoarchitecture of the hippocampal synapses of HD mice in comparison to WT, which 
may underlie functional differences.  
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Figure 9: SYN expression before and after LTP induction in proximal stratum 
radiatum from WT and Het mice 
(A) Representative SRRF images in proximal stratum radiatum of SYN before (control) 
or after cLTP induction in WT or het. Top left: WT control, top right: WT cLTP, bottom 
left: Het control, bottom right: Het cLTP. (B) SYN size for all conditions. (C) SYN 
fluorescent intensity for all conditions. AU stands for arbitrary units (D) SYN density 
(nans-objects/per µm2) for WT control, WT cLTP, Het control, and Het cLTP. (E) 
Cumulative frequency graph for SYN size comparing WT control and Het control tissue. 
(F) Cumulative frequency graph for SYN size comparing WT control and WT cLTP 
tissue. (G) Cumulative frequency graph for SYN size comparing Het control and Het 
cLTP tissue. (H) Cumulative frequency graph for SYN intensity comparing WT control 
and WT cLTP tissue. (I) Cumulative frequency graph for SYN intensity comparing WT 
control and WT cLTP tissue. (J) Cumulative frequency graph for SYN intensity 
comparing Het control and Het cLTP tissue.  
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3-7 SRRF imaging of Synaptophysin in distal stratum radiatum in WT and 
heterozygous mice. 
In distal stratum radiatum (i.e. 500-800 µm away from CA3 cell bodies);(fig. 10), we 
found a significant difference in SYN size (fig. 10b);(one-way ANOVA, p < 0.001). 
More specifically, in similar fashion to proximal areas, het SYN size in the basal 
condition (control) was significantly larger than WT control SYN size. Furthermore, 
cLTP significantly reduced SYN size in het tissue but had no effect in WT tissue (post-
hoc Tukey tests for WT control vs. WT cLTP, p = 0.935; WT control vs. Het control, p < 
0.001; WT control vs. Het cLTP, p = 0.913; WT cLTP vs. Het control, p < 0.001; WT 
cLTP vs. Het cLTP, p = 0.100; Het control vs. Het cLTP, p < 0.001; WT control: N=3, 
n=5, n1=10, n2=5117; WT cLTP: N=3, n=6, n1=12, n2=6146; Het control: N=3, n=6, 
n1=12, n2=5830; Het cLTP: N=3, n=6, n1=12, n2=5892). It is clear from these results that 
the pre-synaptic alterations in SYN size described above are apparent across stratum 
radiatum in presymptomatic HD mice. In addition, we found a significant difference in 
SYN intensity (fig. 10c, one-way ANOVA, p < 0.001). More specifically, cLTP 
significantly increased SYN intensity in WT tissue but showed no significant effect in 
Het tissue (post-hoc Tukey tests for WT control vs. WT cLTP, p < 0.001; WT control vs. 
Het control, p = 0.009; WT control vs. Het cLTP, p = 0.011; WT cLTP vs. Het control, p 
< 0.001; WT cLTP vs. Het cLTP, p < 0.001; Het control vs. Het cLTP, p = 0.881; WT 
control: N=3, n=5, n1=10, n2=5117; WT cLTP: N=3, n=6, n1=12, n2=6146; Het control: 
N=3, n=6, n1=12, n2=5830; Het cLTP: N=3, n=6, n1=12, n2=5892). When measuring 
SYN density (fig. 10d, number of nano-objects per image) we found no significant 
differences in distal stratum radiatum within genotypes or treatment conditions (one-way 
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ANOVA, p = 0.559; post-hoc Tukey tests for WT control vs. WT cLTP, p > 0.999; WT 
control vs. Het control, p = 0.916; WT control vs. Het cLTP, p = 0.878; WT cLTP vs. Het 
control, p =0.912; WT cLTP vs. Het cLTP, p = 0.854; Het control vs. Het cLTP, p = 
0.481;WT control: N=3, n=5, n1=10; WT cLTP: N=3, n=6, n1=12; Het control: N=3, n=6, 
n1=12; Het cLTP: N=3, n=6, n1=12). From these results, it is apparent that in distal 
stratum radiatum, SYN size is not affected after cLTP in WT tissue and is significantly 
decreased after cLTP in het tissue (fig.11 b,e,f,g). Unlike in proximal areas of 
hippocampus however, cLTP seems to have no effect on het SYN intensity in distal areas 
(fig.11 c,h,i,j) indicating that the phenomenon experienced in proximal areas of stratum 
radiatum in het mice does not translate to distal areas. Similar to GluA2, we observe no 
discernable difference in SYN density (fig.11 d) in any of the conditions.  
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Figure 10: SYN expression before and after LTP induction in distal stratum 
radiatum from WT or Het mice 
(A) Representative distal SRRF images of SYN in all conditions. Top left: WT control, 
top right: WT cLTP, bottom left: Het control, bottom right: Het cLTP. (B) SYN size for 
all conditions. (C) SYN fluorescent intensity for all conditions. AU stands for arbitrary 
units (D) SYN density (nano-objects/per µm2) for WT control, WT cLTP, Het control, 
and Het cLTP. (E) Cumulative frequency graph for SYN size comparing WT control and 
Het control tissue. (F) Cumulative frequency graph for SYN size comparing WT control 
and WT cLTP conditions. (G) Cumulative frequency graph for SYN size comparing Het 
control and Het cLTP tissue. (H) Cumulative frequency graph for SYN intensity 
comparing WT control and WT cLTP tissue. (I) Cumulative frequency graph for SYN 
intensity comparing WT control and WT cLTP tissue. (J) Cumulative frequency graph 
for SYN intensity comparing Het control and Het cLTP tissue.  
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3-8 Nearest neighbour analysis of GluA2 and Synaptophysin along stratum 
radiatum in WT and heterozygous mice.  
 It has been shown that proteins and their associated functions at pre-synaptic 
terminals and at the post-synaptic density (PSD) are strongly correlated, and this 
correlation in protein structure and function may underlie structural and synaptic 
plasticity (Schikorski and Stevens, 1997; Hruska et al., 2018). Furthermore, it was 
recently shown that organization of NMDARs on a nanoscale level is dependent on 
subunit composition (Ladépêche et al., 2018). Here, in order to better understand the 
nanoarchitecture of the synapse and its pre and post-synaptic proteins, we used a NN 
analysis to determine the average distance between the AMPAR subunit GluA2 and its 
nearest pre-synaptic SYN neighbour in both proximal and distal (fig. 11,12) areas of 
hippocampus in WT control, WT cLTP, Het control, and Het cLTP tissue.  
 In proximal stratum radiatum, we observed a significant overall difference in 
GluA2 to SYN distance via NN analysis (fig. 11). We created Voronoi plots to visualize 
the 2D-distribution of the distance between nearest GluA2 and SYN neighbours, with 
cool colours (blue, black) representing closer distances and warmer colours (red, orange 
yellow) representing further distances (fig. 11b,12b). Specifically, cLTP significantly 
increased the distance between NN in het tissue, but had no effect on WT tissue (fig. 11c, 
d)(one-way ANOVA, p < 0.001. Post-hoc Tukey tests for WT control vs. WT cLTP, p = 
0.376; WT control vs. Het Control, p = 0.770; WT control vs. Het cLTP, p = 0.004; WT 
cLTP vs. Het Control, p = 0.034; WT cLTP vs. Het cLTP, p < 0.001; Het Control vs. Het 
cLTP, p = 0.007; WT control: N=3, n=6, n1=12, n2=5869; WT cLTP: N=3, n=5, n1=10, 
n2=7003; Het control: N=3, n=6, n1=12, n2=7319; Het cLTP: N=3, n=6, n1=12, n=6758).  
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 In distal areas of hippocampus, we did not observe any significant overall 
differences in GluA2 to SYN distance via NN analysis (fig.12c, d)(one-way ANOVA, p = 
0.186. Post-hoc Tukey tests for WT control vs. WT cLTP, p = 0.669; WT control vs. Het 
Control, p = 0.797; WT control vs. Het cLTP, p = 0.130; WT cLTP vs. Het Control, p = 
0.996; WT cLTP vs. Het cLTP, p < 0.715; Het Control vs. Het cLTP, p = 0.566; WT 
control: N=3, n=5 n1=10, n2=5920; WT cLTP: N=3, n=6, n1=12, n2=6514; Het control: 
N=3, n=6, n1=12, n2=6606; Het cLTP: N=3, n=6, n1=12, n2=6662). From these data, it is 
evident that the changes in the distance between pre- and postsynaptic structures as 
detected by NN analysis of SYN and GluA2 puncta occur in proximal stratum radiatum 
but not in distal areas. Thus, it is possible that at this very early stage of HD, anomalies 
related to how the pre and post-synapse structure are only apparent in proximal stratum 
radiatum and have yet to propagate to distal areas. 
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Figure 11: NN analysis of SRRF images for GluA2 and SYN in proximal stratum 
radiatum in WT control, WT cLTP, Het Control, and Het cLTP conditions. 
(A) Representative composite images showing GluA2 in green and SYN in red. Top left: 
WT control; top right: WT cLTP; bottom right: Het control; bottom left: Het cLTP. (B) 
Representative Voronoi plots for each condition. (C) Cumulative frequency plot for 
GluA2 NN-to-SYN analysis. (D) Bar graph displaying GluA2 NN-to-SYN distance (µm) 
for each condition. 
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Figure 12: NN analysis of SRRF images for GluA2 and SYN in distal stratum 
radiatum in WT control, WT cLTP, Het Control, and Het cLTP conditions. 
(A) Representative composite images showing GluA2 in green and SYN in red. Top left: 
WT control; top right: WT cLTP; bottom right: Het control; bottom left: Het cLTP. (B) 
Representative Voronoi plots for each condition. (C) Cumulative frequency plot for 
GluA2 NN to SYN analysis. (D) Bar graph displaying GluA2 NN to SYN distance (µm) 
for each condition. 
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Figure 13: Summary of SRRF size, intensity, and density results. 
Schematic displaying WT control, WT cLTP, Het control, and Het cLTP pre and post-
synaptic terminals (green) with red circles representing SYN, and purple circles 
representing GluA2. Here, the size of each circle represents the change in nano-object 
size, and the transparency of each circle represents the fluorescent intensity. Each 
terminal has one representative circle to exemplify no change in nano-object density.  
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4-0 Discussion 
4-1 Early synaptic deficits in HD  
 Deciphering the cellular and synaptic underpinnings of prodromal HD may allow 
for a breakthrough in disease treatment that has evaded clinicians and researchers alike 
since the beginning of HD investigation. It is already evident based on the literature that 
an abundance of presymptomatic aberrations in synaptic transmission and cognitive 
function exist in HD animal models. Specifically, at 2 months of age before the onset of 
behavioural symptoms that occur at around 6 months, YAC128 mice exhibited learning 
deficits on the rotarod test of motor coordination (Van Raamsdonk et al., 2005b). 
Furthermore, transgenic R6/2 HD mice, unlike controls, swam in random patterns with 
little to no reference to the location of the platform in a Morris water maze, indicating an 
impairment in spatial cognition (Murphy et al., 2000).  
In conjunction with early behavioural abnormalities related to cognitive function, 
presymptomatic deficits in synaptic transmission have also been well documented in HD, 
but mostly in the striatum. For example, young R6/2 mice showed increased neuronal 
cell-membrane input resistance, lower stimulus intensity to evoke action potentials, and 
reduced paired-pulse facilitation in comparison to WT controls (Klapstein et al., 2001). 
Moreover, in presymptomatic 1-month old YAC128 mice, AMPAR-mediated 
postsynaptic currents and pre-synaptic glutamate release were significantly increased, 
corresponding to an increased responsiveness of MSNs to cortical stimulation. 
Additionally, it was recently postulated that dysregulated AMPAR surface diffusion and 
failure to stabilize these receptors after cLTP induction may underlie deficits in synaptic 
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transmission observed in a multitude of HD mouse models (Zhang et al., 2018). 
Presymptomatic deficits in the striatum have been well explored, however, 
presymptomatic deficits of the HD hippocampus have been largely understudied. Further 
investigation into the hippocampus in early HD could help provide more information 
surrounding the cellular mechanisms underlying early disease progression in cognitive 
function. It is important to reiterate here that all experiments conducted for the purposes 
of this thesis were carried out in a clinically relevant mouse model of HD, Q175FDN. 
This model shows slowly progressing disease phenotype, expresses human mhtt, and 
closely resembles the genetic mutation that causes HD. Therefore, this model is highly 
valuable for pre-clinical investigation (Southwell et al., 2016). 
To illuminate subtle deficits at a presymptomatic stage of a disease, it is often 
necessary to explore the disease state at a cellular level. One method of cellular 
investigation that is often employed by neuroscience researchers is measuring electrical 
properties of neurons. It is apparent that the majority of electrophysiological evidence 
associated with HD has been executed via conventional methods, specifically via 
intracellular recording such as whole-cell patch clamping or extracellular recording by 
measuring field potentials. Although these techniques are accurate and utilized often, they 
lack the ability to examine the spatial properties of a specific brain area as a whole. We 
utilized multi-electrode array electrophysiology to examine the hippocampus, a brain area 
that has been implicated in HD and is well-known for its role in learning and memory and 
plays a key role in multi-modal sensory integration (Zola-Morgan and Squire, 1990; 
Squire and Zola-Morgan, 1991). Moreover, a high degree of transcriptional variability 
across the axes (Thompson et al., 2008; Cembrowski et al., 2016) of hippocampus have 
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been described, making simultaneous spatial investigation of its electrophysiological 
properties very important.  
4-2 TBS and HFS LTP in presymptomatic HD  
Here, using the MED64 system, we examined LTP along the stratum radiatum of 
hippocampus in 3-month old, presymptomatic Q175FDN HD mice. We observed a 
significant impairment in LTP induced by TBS in distal areas of the Schaffer collateral 
synapse of hippocampus. Specifically, these impairments were observed from distances 
of 450-750 µm away from the stimulating electrode but not in areas close by. Our 
electrophysiological findings are unique for a number of reasons; firstly, this deficit is 
observed 3 months before the onset of any quantifiable behavioural HD phenotype in the 
Q175FDN mice, indicating it could be among the earliest detectable synaptic aberrations 
associated with HD. Furthermore, it is unlikely that this impairment would have been 
detected as easily with conventional electrophysiology, as it was only apparent at distal 
electrodes in the electrode array. It is also important to note that in LTP induced by HFS, 
we observed no discernable differences between WT and het mice, indicating that the 
pattern of synaptic activity is critical. Firstly, TBS is modeled after the endogenous 
complex spike activity that occurs either during the positive or negative phases of 
hippocampal theta rhythm (Perez et al., 1999), thus arguably making it a more 
physiologically-relevant stimulation paradigm than HFS. Therefore, our results reflect a 
more physiologically-accurate deficit in LTP that would likely be observed in human HD 
than if our deficit was observed with HFS. Similar to our results, it was found that in an 
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animal model of Down syndrome, mice showed significant impairments in TBS induced 
LTP but not HFS (Costa and Grybko, 2005).  
It is also well known that TBS and HFS rely on different intracellular signaling 
pathways to mediate their effects. For example, TBS requires calpain-1 activation (Zhu et 
al., 2015). Calpains are a family of neutral calcium-dependent proteases that have the 
unique ability to cleave proteins to modify the activity and/or function of their substrates 
(Baudry and Bi, 2016). In general, calpain-1 is required for LTP induction and is 
generally neuroprotective (Baudry and Bi, 2016). Thus, the deficit we observe in TBS-
LTP may be mediated by deficits in calpain-1 in distal areas of presymptomatic HD mice. 
Furthermore, calpains, specifically calpain-2 and its targets, have been implicated in other 
neurodegenerative diseases such as Alzheimer Disease (Patrick et al., 1999; Kimura et al., 
2014), making it likely that calpains also play a role in HD. To test this, we could 
investigate calpain levels in presymptomatic HD mice.  
TBS-induced LTP also requires ERK activation (Selcher et al., 2003). ERKs are 
involved in regulation of important neuronal functions, including synaptic plasticity in 
basal and pathological conditions (Colucci-D’Amato et al., 2003). ERK signaling seems 
to be disturbed in HD, indicating another possible mechanism for our observed LTP 
deficit. For example, at the intercellular level ERK-dependent expression of glutamate 
transporters is decreased by mhtt, leading to increased glutamate signaling and 
excitotoxicity (Milnerwood et al., 2010; Robertson and Bottomley, 2010). Moreover, at 
the intracellular level, mhtt impairs glutamate-induced ERK signaling in both an upstream 
and downstream manner (Roze et al., 2008; Ribeiro et al., 2010). On the other hand, HFS-
induced LTP requires protein kinase A (PKA) activation (Kim et al., 2010). Furthermore, 
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it has been shown that adenosine is released following HFS, but not TBS, to facilitate 
LTP (Cunha et al., 1996). From this, we can infer that intracellular signaling pathways 
related to TBS may be altered early on in HD progression while signaling pathways 
associated with HFS may remain intact.   
4-3 Pre and post-synaptic aberrations in early HD 
Another possible explanation for the observed deficit in LTP in this study could involve 
pre-synaptic abnormalities in the heterozygous Q175FDN mice. It has been shown that 
symptomatic HD mice show a significant reduction in LTP, but LTP could be induced by 
an “enhanced” tetanic stimulation paradigm (Usdin et al., 1999). This indicates that the 
LTP producing mechanism is intact in mutant mice, but their synapses are less able to 
reach the threshold for LTP induction (Usdin et al., 1999). Here, it is possible that the 
smaller fEPSPs  observed at distal areas of hippocampus in HD mice due to the lower 
gain of input-output relationship are not strong enough to generate the co-operation 
needed to surpass the threshold required for TBS-LTP, while in WT tissue the fEPSPs are 
able to meet the requirements for TBS-LTP. It is possible that the smaller EPSPs are due 
to mutant htt acting at the synaptic terminal to inhibit neurotransmitter release. In 
agreement, WT htt binds to microtubules and synaptic vesicles, is enriched at the pre-
synaptic terminal to enhance BDNF vesicular transport along microtubules (DiFiglia et 
al., 1995; Gutekunst et al., 1995; Sharp et al., 1995; Gauthier et al., 2004). In future 
studies, it would be interesting to investigate if increased stimulation intensity during LTP 
induction could help to overcome the deficit occurring at distal sites of hippocampus. 
Additionally, a recent study that reconstructed a HD cortico-striatal network via a 
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microfluidic chip showed marked changes in fast axonal transport early on in the 
development of the network. Furthermore, significant decreases in vesicular dynamics 
along with increases in mitochondrial motility were observed (Virlogeux et al., 2018). 
Moreover, it has been postulated that early abnormal phosphorylation of synapsin, a 
protein involved in regulating neurotransmitter release, may alter synaptic vesicle 
trafficking and cause impairments in neurotransmission in HD (Liévens et al., 2002). 
Similarly, downregulation of complexin II, a eukaryotic cytoplasmic neuronal protein 
involved in vesicle trafficking, has been observed in different models of HD (Morton and 
Edwardson, 2001; Edwardson et al., 2003). Although mice deficient in complexin II show 
no obvious phenotypical abnormalities, LTP impairments in both CA1 and CA3 regions 
in these mice have been observed (Reim et al., 2001). Thus, it is possible that the LTP 
deficit we observed at distal areas of hippocampus in HD mice is associated with pre-
synaptic abnormalities of synaptic transmission.  
 It is also plausible that our observed deficits in LTP in the distal areas of the 
stratum radiatum are postsynaptic, as alterations in post-synaptic signaling in HD have 
been observed. Specifically, a significant reduction in phospho-ERK-immunopositive 
striatal neurons in response to cortical stimulation was found in Hdh140 knock-in mice 
(Virlogeux et al., 2018). Additionally, in the R6/2 model of HD, mhtt selectively 
decreased the expression of NMDARs at the presymptomatic stage (Cha et al., 1998). 
Involvement of NMDARs in LTP is well documented (Nicoll and Malenka, 1995; Man, 
2011), thus decreased expression of NMDARs could explain the impairments in LTP we 
observe at distal areas of hippocampus. Notably, expanded polyglutamine tracts are 
known to interfere with the ability of huntingtin to interact efficiently with post-synaptic 
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density protein 95 (PSD-95), which could influence the normal functioning of proteins 
anchored in the post-synaptic density, such as NMDARs and AMPARs (Sun et al., 2001). 
PSD-95 is neuronal scaffolding protein concentrated at excitatory synapses that is 
involved in synaptic transmission and synapse development (El-Husseini et al., 2000). It 
was also found that AMPARs have decreased ligand binding activity in the R6/2 model of 
HD (Cha et al., 1998). Additionally, normal receptor recycling in post-synaptic terminals 
is regulated by many proteins, such as endophilins, that also bind to huntingtin 
(Modregger et al., 2003). 
4-4 Nanoscale investigation of synapses 
It is evident that synaptic deficits in HD can be both pre and post-synaptic, and in all 
likelihood are a combination of both. A key component to understanding the therapeutic 
trajectory of HD patients and disease progression involves understanding synaptic 
dysfunction at the level of individual synapses at the earliest stages of the disease. In 
order to expand upon our characterization of early synaptic abnormalities in HD, we 
sought to visualize and examine the nanoarchitecture of the synapse via novel microscopy 
techniques that are more sensitive to synaptic abnormalities than population 
electrophysiological recordings. These techniques, currently known as super resolution 
imaging, have the ability to surpass the intrinsic diffraction limit associated with light, 
thereby allowing researchers to investigate nanoscale objects that were once deemed 
impossible to distinguish.  
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4-5 Investigation of synaptic nanoarchitecture via super-resolution imaging   
 Light microscopy has been a staple of scientific investigation for centuries and has 
allowed researchers to discover biological intricacies beyond their wildest aspirations. 
Until recently however, light microscopy was limited by the intrinsic diffraction limit or 
“spreading out” of light when it passes through a small aperture or is focused on a very 
small area (Huang et al., 2010). Application of super-resolution imaging presents a 
unique opportunity to neuroscience researchers in particular, who can now investigate 
nanoscale architecture, organization, and movement of components of the synaptic cleft 
in order to achieve a more robust understanding of the synapse in both basal and disease 
conditions.  
Synaptic transmission is maintained by an intricate, sub-cellular molecular 
nanoarchitecture. Even subtle changes to synapse structure can drive functional changes 
during experience-dependent plasticity and pathological disorders (Fromer et al., 2014). 
For example, recently via stochastic optical reconstruction microscopy (STORM), trans-
synaptic molecular “nanocolumns” consisting of pre-synaptic clusters of regulatory 
proteins were found. These proteins are tightly clustered and aligned with post-synaptic 
receptors and scaffolding proteins, which have higher incidences of vesicle-fusion during 
evoked action potentials (Tang et al., 2016). This is indicative of synaptic nano-
organization that preferentially controls neurotransmitter release at sites directly opposed 
to post-synaptic receptors. Furthermore, NMDAR activation triggered distinct phases of 
plasticity in which post-synaptic reorganization was followed by nanoscale realignments 
trans-synaptically (Tang et al., 2016). Furthermore, via stimulated emission depletion 
(STED) super-resolution microscopy, it was found that spine synapses, both in vivo and 
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in vitro, contain discrete and aligned modules of pre and post-synaptic proteins whose 
number, but not size, correlates positively with spine size (Hruska et al., 2018). 
Moreover, it was revealed that NMDAR-dependent increases in spine size were 
accompanied by enhanced mobility along the synaptic cleft of both pre and post-synaptic 
proteins (nano-clusters) that remained aligned with one another and increased in number 
with increasing spine size (Hruska et al., 2018). These results indicate that pre and post-
synaptic proteins maintain tight spatial and temporal nanoscale regulation with one 
another during activity dependent plasticity. Moreover, in one of the earliest super-
resolution microscopy experiments, researchers exemplified nanoscale organization on 
both pre and post synaptic neurons. Specifically, on the pre-synaptic side they showed 
highly oriented organization of scaffolding proteins, while on the post-synaptic neuron 
they discovered laminar organization of PSD proteins and synapse-to-synapse variability 
in lateral positioning of neurotransmitter receptors (Dani et al., 2010). Furthermore, it was 
shown for the first time by this group that a large number of synapses in the accessory 
olfactory bulb (AOB) were immature when undergoing activity-dependent plasticity 
paradigms (Dani et al., 2010). This is indicative of the ability of super-resolution imaging 
to elucidate novel synaptic traits in dense scattering brain tissue with nanometer-scale 
precision.  
4-6 Early changes in synaptic nanoarchitecture in HD via SRRF  
 In the present study, we utilized SRRF imaging, an open source ImageJ super-
resolution plugin capable of achieving high spatial resolutions on the XY plane 
(Gustafsson et al., 2016) to investigate pre and post-synaptic nanoarchitecture in WT and 
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presymptomatic heterozygous Q175FDN HD mice. Furthermore, each genotype was also 
subjected to a cLTP paradigm in order to investigate the effects of activity-dependent 
synaptic plasticity on the nanoarchitecture of the synapse.  
To assess pre-synaptic nanoarchitecture, we selected the ubiquitous neuronal 
protein SYN that spans the synaptic vesicle membrane four times. SYN is an integral 
component of pre-synaptic architecture, accounting for approximately 10% of synaptic 
vesicle protein content (Gordon and Cousin, 2013). To assess post-synaptic 
nanoarchitecture, specifically a protein closely associated with synaptic transmission, we 
selected the AMPAR subunit GluA2. AMPARs are primarily located at excitatory 
synapses, where they mediate the majority of fast synaptic transmission and play a key 
role in synaptic plasticity (Huganir and Nicoll, 2013). Thus, it is possible that AMPAR 
dysfunction is contributing to the LTP impairments we observed at distal areas of 
hippocampus in prodromal HD mice.  
In our study, via SRRF imaging, we examined clusters of GluA2 receptors known 
as puncta or “nano-objects”. Specifically, we analyzed GluA2 puncta size, fluorescence 
intensity, and density. Our results show that in WT tissue, cLTP increases GluA2 puncta 
size both proximally and distally. This aligns with previous results that show enlarged 
dendritic spines after cLTP via STED imaging (Hruska et al., 2018). Interestingly, in het 
tissue, cLTP reduced the size of GluA2 puncta in both proximal and distal areas. 
Moreover, GluA2 puncta were much larger in het control conditions when compared to 
WT control. This indicates a robust basal difference in AMPAR cluster size between WT 
and HD tissue, possibly explaining the genotype difference we observed in I/O, as well as 
an opposing effect of early activity-dependent synaptic transmission between the two 
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genotypes. In these cLTP experiments, tissue was fixed with paraformaldehyde 10 
minutes after cLTP. electrophysiological LTP experiments typically carry out 
measurements up to 60 minutes, making 10 min an early time point of synaptic plasticity. 
Although studying early phases of activity-dependent plasticity can elucidate vital results, 
it is also of future interest to study later time-points leading up to 60 minutes after cLTP.  
Research involving changes in AMPAR localization in HD is limited, however it 
was recently found that the HD causing mutation leads to dysregulated AMPAR surface 
diffusion and AMPARs failing to stabilize after cLTP in the hippocampus of multiple 
rodent models of HD (Zhang et al., 2018). It is important to note that these reported 
changes occurred at later stages of the disease, in relation to a more overt behavioural 
phenotype associated with HD. In contrast, The changes we observed in the current study 
highlight some of the very earliest alterations in synaptic architecture associated with the 
presymptomatic stages of HD.  
We also investigated GluA2 fluorescence intensity as another measure of synaptic 
architecture. It was found that in WT tissue, cLTP decreased fluorescence intensity. 
Taken together with the increase in GluA2 size, these results indicate that in WT animals 
during the early stages of activity-dependent synaptic plasticity, GluA2 puncta are 
migrating toward release sites in anticipation of insertion into the post-synaptic 
membrane (Liao et al., 1995; Bredt and Nicoll, 2003). GluA2 puncta in basal conditions 
(controls) are much less intense in het tissue than WT, but interestingly they show a 
robust increase in intensity after cLTP. This is indicative of GluA2 puncta in 
presymptomatic HD tissue organizing themselves and migrating in a different manner 
than observed in WT tissue. It is well-known that AMPAR trafficking is disturbed in 
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symptomatic HD (Mandal et al., 2011; Zhang et al., 2018), thus the differences we see 
here are likely the earliest manifestations of disturbed AMPAR trafficking and altered 
synaptic architecture in HD.  
We also investigated GluA2 puncta density, a measure of how many puncta were 
present in each image, and found no significant differences between any groups in either 
proximal or distal areas. This indicates that although AMPARs appear to be moving 
around the synapse in conjunction with changes in nanoarchitecture, the number of 
GluA2 nano-objects remains unaltered. These findings are supported by a vast amount of 
research that implicates de novo protein synthesis as a characteristic of long-term 
plasticity, while here we are only measuring the early stages of LTP (Nayak et al., 1998; 
Dudai, 2002; Matsuo et al., 2008). It is important to note here however, that our cLTP 
protocol is well established (Kopec et al., 2006; Lin et al., 2008) and leads to long term 
synaptic changes. Overall, it is obvious that even at a very early stage of the disease, long 
before any detectable behavioural phenotype (Southwell et al., 2016) or overt 
electrophysiological deficits that can be measured conventionally, there are robust 
differences in AMPAR nanoarchitecture and localization in HD mice. To the best of our 
knowledge, these aberrations are of the earliest cellular manifestations associated with the 
pathophysiology of the disease. 
  When investigating our presynaptic marker SYN, results were markedly different 
than GluA2. In terms of SYN nano-object size, we observed no differences after cLTP in 
either proximal or distal areas in WT tissue. This result was expected, as this form of 
cLTP is NMDAR-dependent and known to rely largely on post-synaptic changes (Kopec 
et al., 2006). However, in het tissue SYN size was larger at basal conditions than in WT 
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tissue and underwent a marked increase after cLTP, potentially explaining the basal 
difference we observed between genotypes when measuring I/O. Taken together, it is 
apparent here that presynaptic alterations in nanoarchitecture are also occurring in 
prodromal HD, although not in the same manner as postsynaptic changes. Previous work 
has postulated that impairments in synapsin I phosphorylation in the striatum of R6/2 
mice may alter synaptic vesicle trafficking and contribute to impaired neurotransmission 
in HD (Liévens et al., 2002).  
When examining SYN intensity, we observed a dramatic increase in fluorescence 
intensity in WT tissue after cLTP. This observation indicates that SYN is clustering 
together following cLTP. This aligns well with research that postulates a significant role 
of SYN in vesicle packaging, trafficking, and release (Alder et al., 1992; Mullany and 
Lynch, 1998). Thus, an increase in neurotransmitter release associated with LTP would 
mean an increase in SYN around release sites. In HD tissue, there was an observed 
increase in SYN intensity at proximal sites, but it was much less dramatic. At distal sites, 
there was no observable increase in SYN intensity, indicating that not only is SYN 
trafficking impaired in HD, but this impairment seems to worsen further along stratum 
radiatum. Here, it is important to note that SYN intensity does not increase in distal areas 
of hippocampus in het tissue. This is imperative because if the physiological mechanisms 
underlying SYN intensity is a critical feature of early LTP, then the lack of intensity 
increase observed at distal sites of the HD hippocampus could help explain why TBS-
LTP is impaired at distal sites of the HD hippocampus. These data also indicate that 
although SYN seem to be clustering around pre-synaptic release sites in HD tissue during 
early stages of LTP, it is not occurring as efficiently as in WT, indicating a very early pre-
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synaptic nanoarchitectural anomaly in prodromal HD. Much like we observed with 
GluA2, there were no changes in SYN density. This indicates that despite the robust 
changes in nano-organization, the number of SYN nano-objects remained the same across 
all conditions.  
 In addition to the analysis parameters described above, we investigated movement 
of GluA2 and SYN nano-objects. This paradigm, coined “nearest neighbour” (NN) 
analysis allowed us to measure changes in GluA2 and SYN movement across all 
conditions in both proximal and distal areas of stratum radiatum. This concept was 
originally applied using monte-carlo simulation in combination with electron micrographs 
to interpret synaptic cross-talk between hippocampal neurons (Rusakov et al., 1999). 
From this experiment it was found that NMDAR-mediated crosstalk is likely to occur 
between excitatory synapses in the hippocampus, indicating that NN analysis is a useful 
tool for measuring synaptic communication. More recently, NN analysis was applied in 
conjunction with STORM super-resolution imaging to examine NMDAR nano-object 
localization to determine if receptors were located in synaptic or extrasynaptic areas in a 
model of NMDAR encephalitis, again elucidating the effectiveness of NN analysis for 
measuring synaptic protein migration (Ladépêche et al., 2018). With respect to our 
results, in proximal areas of hippocampus, we found no significant difference in nano-
object migration in WT tissue after cLTP. From this we interpret that after cLTP, GluA2 
and SYN puncta do not migrate away from each other along the synaptic cleft. However, 
in het tissue, we did observe a significant increase in NN distance after cLTP. Here, it is 
possible that activity-dependent transmission in HD mice is causing nanoscale pre and 
post-synaptic protein misalignment. It is well known that activation of extrasynaptic 
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NMDARs promotes pro-death gene expression and cell-death signaling (Parsons and 
Raymond, 2014). Furthermore, elevated extrasynaptic NMDAR activity is apparent in the 
pathology of HD (Hardingham and Bading, 2010; Milnerwood and Raymond, 2010). 
Evidence surrounding extrasynaptic AMPARs is limited, however the results observed 
here are again indicative of early changes in synaptic nanoarchitecture in relation to 
activity-dependent transmission in prodromal HD. 
4-7 Caveats & Future Direction 
 As is the case with any scientific study, there are some drawbacks here that 
warrant acknowledgement. Firstly, the MEA experiments were not carried out in an equal 
number of male and female mice, thus sex differences could be an influencing factor. It is 
also important to note that the SRRF algorithm only accounts for the XY plane of images, 
therefore the 16 µm depth of our re-sections (Z-plane) is not accounted for during SRRF 
as we did not utilize confocal microscopy.  
 This thesis identified clear detrimental effects of mHtt on hippocampal structure 
and function in presymptomatic HD. Furthermore, alterations in synaptic 
nanoarchitecture associated with early activity-dependent plasticity were identified. In the 
future, executing similar cLTP experiments at different time points (i.e. 10, 60, and 180 
minutes after LTP) would provide a more in-depth investigation into synaptic alterations 
over the course of LTP. It would also be of interest to complete similar 
electrophysiological and SRRF imaging experiments at different time points during the 
progression of HD, to measure the severity and acceleration of synaptic aberrations as the 
disease worsens. Furthermore, investigating intracellular Ca2+ pathways discussed in this 
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thesis such as PKA and calpain signaling, and how these pathways are affected in the 
early HD brain would be of great interest.   
4-8 Interpretations & Conclusion 
 To the best of our knowledge, the present thesis has identified the earliest known 
synaptic anomalies in the HD hippocampus. These findings were attainable due to the 
increasingly diverse methodologies available in neuroscience. In combination with one 
another, our electrophysiological and super-resolution microscopy results suggest that 
there are numerous significant aberrations at the synaptic level in the hippocampus 
associated with presymptomatic stages of HD. Researchers and clinicians alike have long 
been intrigued by the cognitive and psychiatric deficits associated with HD as they likely 
stem from physiological abnormalities that eventually worsen as the disease progresses 
into its later stages. So much of the research surrounding HD is associated with the 
striatum, however focusing on other brain areas such as hippocampus will allow the HD 
research community to gain further understanding into the global nature of the disease. 
HD is a devastating disease that requires further investigation into specific cellular and 
sub-cellular aberrations associated with its early stages. As more sophisticated 
methodologies and subsequent development of therapeutic approaches become available, 
they may eventually allow us to discover and implement a viable treatment option for 
those living and dying with this insidious condition.  
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